Western New England Bancorp, Inc 10-Q for FY2022 Q1
Western New England Bancorp, Inc. (WNEB)
About this 10-Q
Western New England Bancorp, Inc filed this 10-Q on May 6, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).
Headline figures
Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net income
- $5.32M
- down 8.2% from net income of $5.79M a year earlier
- Diluted EPS
- $0.24
- unchanged from $0.24 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended
or
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________ to ___________
Commission
File Number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification Number) |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | |
| Non-accelerated filer ☐ | Smaller reporting company |
| Emerging
growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
At May 2, 2022 the registrant had shares of common stock, $0.01 par value, issued and outstanding.
TABLE OF CONTENTS
FORWARD–LOOKING STATEMENTS
We may, from time to time, make written or oral “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements contained in our filings with the Securities and Exchange Commission (the “SEC”), our reports to shareholders and in other communications by us. This Quarterly Report on Form 10-Q contains “forward-looking statements” with respect to the Company’s financial condition, liquidity, results of operations, future performance, business, measures being taken in response to the coronavirus disease 2019 (“COVID-19”) pandemic and the impact of COVID-19 on the Company’s business. Forward-looking statements may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” and “potential.” Examples of forward-looking statements include, but are not limited to, estimates with respect to our financial condition, results of operations and business that are subject to various factors which could cause actual results to differ materially from these estimates. These factors include, but are not limited to:
| ● | the duration and scope of the COVID-19 pandemic and the local, national and global impact of COVID-19; |
| ● | actions governments, businesses and individuals take in response to the COVID-19 pandemic; |
| ● | the speed and effectiveness of any COVID-19 vaccines and treatment developments and their deployment, including public adoption rates of any COVID-19 vaccines; |
| ● | the emergence of new COVID-19 variants, such as the Omicron variant, and the response thereto; |
| ● | the pace of recovery when the COVID-19 pandemic subsides; |
| ● | changes in the interest rate environment that reduce margins; |
| ● | the effect on our operations of governmental legislation and regulation, including changes in accounting regulation or standards, the nature and timing of the adoption and effectiveness of new requirements under the Dodd-Frank Act Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank Act”), Basel guidelines, capital requirements and other applicable laws and regulations; |
| ● | the highly competitive industry and market area in which we operate; |
| ● | general economic conditions, either nationally or regionally, resulting in, among other things, a deterioration in credit quality; |
| ● | changes in business conditions and inflation; |
| ● | changes in credit market conditions; |
| ● | the inability to realize expected cost savings or achieve other anticipated benefits in connection with business combinations and other acquisitions; |
| ● | changes in the securities markets which affect investment management revenues; |
| ● | increases in Federal Deposit Insurance Corporation deposit insurance premiums and assessments; |
| ● | changes in technology used in the banking business; |
| ● | the soundness of other financial services institutions which may adversely affect our credit risk; |
| ● | certain of our intangible assets may become impaired in the future; |
| ● | our controls and procedures may fail or be circumvented; |
| ● | new lines of business or new products and services, which may subject us to additional risks; |
| ● | changes in key management personnel which may adversely impact our operations; |
| ● | severe weather, natural disasters, acts of war or terrorism and other external events which could significantly impact our business; and |
| ● | other factors detailed from time to time in our SEC filings. |
Although we believe that the expectations reflected in such forward-looking statements are reasonable, actual results may differ materially from the results discussed in these forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except to the extent required by law.
i
PART I – FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS.
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS - UNAUDITED
(Dollars in thousands, except per share data)
| March 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| ASSETS | ||||||||
| Cash and due from banks | $ | $ | ||||||
| Federal funds sold | ||||||||
| Interest-bearing deposits and other short-term investments | ||||||||
| Cash and cash equivalents | ||||||||
| Available-for-sale securities, at fair value | ||||||||
| Held-to-maturity securities, at amortized cost (Fair value of $ | ||||||||
| Marketable equity securities, at fair value | ||||||||
| Federal Home Loan Bank of Boston stock and other restricted stock, at cost | ||||||||
| Loans, net of allowance for loan losses of $ | ||||||||
| Premises and equipment, net | ||||||||
| Accrued interest receivable | ||||||||
| Bank-owned life insurance | ||||||||
| Deferred tax asset, net | ||||||||
| Goodwill | ||||||||
| Core deposit intangible | ||||||||
| Other assets | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
| LIABILITIES: | ||||||||
| Deposits: | ||||||||
| Non-interest-bearing | $ | $ | ||||||
| Interest-bearing | ||||||||
| Total deposits | ||||||||
| Federal Home Loan Bank advances | ||||||||
| Subordinated debt | ||||||||
| Securities pending settlement | ||||||||
| Other liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| SHAREHOLDERS' EQUITY: | ||||||||
| Preferred stock - $ par value, shares authorized, outstanding at March 31, 2022 and December 31, 2021 | ||||||||
| Common stock - $ par value, shares authorized, shares issued and outstanding at March 31, 2022; shares issued and outstanding at December 31, 2021 | ||||||||
| Additional paid-in capital | ||||||||
| Unearned compensation – Employee Stock Ownership Plan | ( | ) | ( | ) | ||||
| Unearned compensation - Equity Incentive Plan | ( | ) | ( | ) | ||||
| Retained earnings | ||||||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | $ | ||||||
See accompanying notes to unaudited consolidated financial statements.
1
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NET INCOME – UNAUDITED
(Dollars in thousands, except per share data)
| Three Months | ||||||||
| Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Interest and dividend income: | ||||||||
| Residential and commercial real estate loans | $ | $ | ||||||
| Commercial and industrial loans | ||||||||
| Consumer loans | ||||||||
| Debt securities, taxable | ||||||||
| Debt securities, tax-exempt | ||||||||
| Marketable equity securities | ||||||||
| Other investments | ||||||||
| Short-term investments | ||||||||
| Total interest and dividend income | ||||||||
| Interest expense: | ||||||||
| Deposits | ||||||||
| Long-term debt | ||||||||
| Subordinated debt | ||||||||
| Total interest expense | ||||||||
| Net interest and dividend income | ||||||||
| (Credit) provision for loan losses | ( | ) | ||||||
| Net interest and dividend income after (credit) provision for loan losses | ||||||||
| Non-interest income: | ||||||||
| Service charges and fees | ||||||||
| Income from bank-owned life insurance | ||||||||
| Loss on available-for-sale securities, net | ( | ) | ( | ) | ||||
| Net unrealized loss on marketable equity securities | ( | ) | ( | ) | ||||
| Gain on sale of mortgages | ||||||||
| Gain on non-marketable equity investments | ||||||||
| Other income | ||||||||
| Total non-interest income | ||||||||
| Non-interest expense: | ||||||||
| Salaries and employees benefits | ||||||||
| Occupancy | ||||||||
| Furniture and equipment | ||||||||
| Data processing | ||||||||
| Professional fees | ||||||||
| FDIC insurance assessment | ||||||||
| Advertising | ||||||||
| Other expenses | ||||||||
| Total non-interest expense | ||||||||
| Income before income taxes | ||||||||
| Income tax provision | ||||||||
| Net income | $ | $ | ||||||
| Earnings per common share: | ||||||||
| Basic earnings per share | $ | $ | ||||||
| Weighted average shares outstanding | ||||||||
| Diluted earnings per share | $ | $ | ||||||
| Weighted average diluted shares outstanding | ||||||||
| Dividends per share | $ | $ | ||||||
See accompanying notes to unaudited consolidated financial statements.
2
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) – UNAUDITED
(Dollars in thousands)
| Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Net income | $ | $ | ||||||
| Other comprehensive income (loss): | ||||||||
| Unrealized losses on available-for-sale securities: | ||||||||
| Unrealized holding losses | ( | ) | ( | ) | ||||
| Reclassification adjustment for net losses realized in income (1) | ||||||||
| Unrealized losses | ( | ) | ( | ) | ||||
| Tax effect | ||||||||
| Net-of-tax amount | ( | ) | ( | ) | ||||
| Cash flow hedges: | ||||||||
| Reclassification adjustment for termination fee realized in interest expense | ||||||||
| Tax effect | ( | ) | ||||||
| Net-of-tax amount | ||||||||
| Defined benefit pension plan: | ||||||||
| Amortization of defined benefit plans actuarial loss | ||||||||
| Tax effect | ( | ) | ( | ) | ||||
| Net-of-tax amount | ||||||||
| Other comprehensive loss | ( | ) | ( | ) | ||||
| Comprehensive (loss) income | $ | ( | ) | $ | ||||
| (1) | Realized gains and losses on available-for-sale securities are recognized as a component
of non-interest income. The tax effects applicable to net realized gains and losses were $( |
See accompanying notes to unaudited consolidated financial statements.
3
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED
THREE MONTHS ENDED MARCH 31, 2022 AND 2021
(Dollars in thousands, except per share data)
| Common Stock | Additional | Unearned | Unearned Compensation- | Accumulated Other | ||||||||||||||||||||||||||||
| Shares | Par Value | Paid-in
Capital | Compensation- ESOP | Equity Incentive Plan | Retained Earnings | Comprehensive Loss | Total | |||||||||||||||||||||||||
| BALANCE AT DECEMBER 31, 2020 | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||
| Comprehensive income | — | ( | ) | |||||||||||||||||||||||||||||
| Common stock held by ESOP committed to be released ( shares) | — | |||||||||||||||||||||||||||||||
| Share-based compensation - equity incentive plan | — | |||||||||||||||||||||||||||||||
| Forfeited equity incentive plan shares reissued ( shares) | — | ( | ) | |||||||||||||||||||||||||||||
| Common stock repurchased | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
| Issuance of common stock in connection with stock option exercises | ||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with equity incentive plan ( shares) | — | ( | ) | |||||||||||||||||||||||||||||
| Cash dividends declared and paid on common stock ($ per share) | — | ( | ) | ( | ) | |||||||||||||||||||||||||||
| BALANCE
AT MARCH 31, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||
| BALANCE AT DECEMBER 31, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||
| Comprehensive income | — | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Common stock held by ESOP committed to be released ( shares) | — | |||||||||||||||||||||||||||||||
| Share-based compensation - equity incentive plan | — | |||||||||||||||||||||||||||||||
| Forfeited equity incentive plan shares ( shares) | — | ( | ) | |||||||||||||||||||||||||||||
| Forfeited equity incentive plan shares reissued ( shares) | — | ( | ) | |||||||||||||||||||||||||||||
| Common stock repurchased | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
| Issuance of common stock in connection with stock option exercises | ||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with equity incentive plan | ( | ) | ||||||||||||||||||||||||||||||
| Cash dividends declared and paid on common stock ($ per share) | — | ( | ) | ( | ) | |||||||||||||||||||||||||||
| BALANCE
AT MARCH 31, 2022 | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||||||||||||||
See accompanying notes to unaudited consolidated financial statements.
4
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED
(Dollars in thousands)
| Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net income | $ | $ | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| (Credit) provision for loan losses | ( | ) | ||||||
| Depreciation and amortization of premises and equipment | ||||||||
| (Accretion) amortization of purchase accounting adjustments, net | ( | ) | ||||||
| Amortization of core deposit intangible | ||||||||
| Net amortization of premiums and discounts on securities and mortgage loans | ||||||||
| Net amortization of premiums on subordinated debt | ||||||||
| Share-based compensation expense | ||||||||
| ESOP expense | ||||||||
| Gain on sale of mortgages | ( | ) | ||||||
| Principal balance of loans originated for sale | ( | ) | ||||||
| Principal balance of loans sold | ||||||||
| Net loss on available-for-sale securities | ||||||||
| Net change in unrealized loss on marketable equity securities | ||||||||
| Income from bank-owned life insurance | ( | ) | ( | ) | ||||
| Net change in: | ||||||||
| Accrued interest receivable | ( | ) | ||||||
| Other assets | ( | ) | ||||||
| Other liabilities | ||||||||
| Net cash provided by operating activities | ||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchases of held-to-maturity securities | ( | ) | ( | ) | ||||
| Proceeds from calls, maturities and principal collections of held-to-maturity securities | ||||||||
| Purchases of available-for-sale securities | ( | ) | ||||||
| Proceeds from sales and redemption of available-for-sale securities | ||||||||
| Proceeds from calls, maturities, and principal collections of available-for-sale securities | ||||||||
| Loan originations and principal payments, net | ( | ) | ( | ) | ||||
| Redemption of Federal Home Loan Bank of Boston stock | ||||||||
| Proceeds from sale of portfolio mortgages | ||||||||
| Purchases of premises and equipment | ( | ) | ( | ) | ||||
| Proceeds from payout on bank-owned life insurance | ||||||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Net increase in deposits | ||||||||
| Repayment of long-term debt | ( | ) | ( | ) | ||||
| Cash dividends paid on common stock | ( | ) | ( | ) | ||||
| Common stock repurchased | ( | ) | ( | ) | ||||
| Issuance of common stock in connection with stock option exercises | ||||||||
| Net cash provided by financing activities | ||||||||
| NET CHANGE IN CASH AND CASH EQUIVALENTS: | ( | ) | ||||||
| Beginning of period | ||||||||
| End of period | $ | $ | ||||||
| Supplemental cash flow information: | ||||||||
| Interest paid | $ | $ | ||||||
| Taxes paid | ||||||||
| Net change in cash due to broker for common stock repurchased | ( | ) | ||||||
See the accompanying notes to unaudited consolidated financial statements.
5
WESTERN NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
MARCH 31, 2022
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations and Basis of Presentation. Western New England Bancorp, Inc. (“Western New England Bancorp,” “WNEB,” “Company,” “we,” or “us”) is a Massachusetts-chartered stock holding company for Westfield Bank, a federally-chartered savings bank (“Bank”).
The
Bank operates
Wholly-owned Subsidiaries of the Bank. Elm Street Securities Corporation, WFD Securities, Inc. and CSB Colts, Inc., are Massachusetts chartered securities corporations, formed for the primary purpose of holding qualified securities. WB Real Estate Holdings, LLC, is a Massachusetts-chartered limited liability company that holds real property acquired as security for debts previously contracted by the Bank.
Principles of Consolidation. The consolidated financial statements include the accounts of Western New England Bancorp, the Bank, CSB Colts, Inc., Elm Street Securities Corporation, WB Real Estate Holdings, LLC and WFD Securities, Inc. All material intercompany balances and transactions have been eliminated in consolidation.
Estimates. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses for each. Actual results could differ from those estimates. An estimate that is particularly susceptible to significant change in the near-term relates to the determination of the allowance for loan losses.
Basis of Presentation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of our financial condition as of March 31, 2022, and the results of operations, changes in shareholders’ equity and cash flows for the interim periods presented. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results of operations for the year ending December 31, 2022. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to the rules and regulations of the Securities and Exchange Commission.
These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2021, included in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Annual Report”).
Reclassifications. Amounts in the prior period financial statements are reclassified when necessary to conform to the current year presentation.
6
Basic earnings per share represents income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. If rights to dividends on unvested awards are non-forfeitable, these unvested awards are considered outstanding in the computation of basic earnings per share. Diluted earnings per share reflect additional common shares that would have been outstanding if dilutive potential common shares had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential common shares that may be issued by us relate to stock options and certain performance-based restricted stock awards and are determined using the treasury stock method. Unallocated Employee Stock Ownership Plan (“ESOP”) shares are not deemed outstanding for earnings per share calculations. There were no anti-dilutive shares outstanding during the three months ended March 31, 2022 and 2021.
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2022 | 2021 | |||||||
| (In thousands, except per share data) | ||||||||
| Net income applicable to common stock | $ | $ | ||||||
| Average number of common shares issued | ||||||||
| Less: Average unallocated ESOP Shares | ( | ) | ( | ) | ||||
| Less: Average unvested equity incentive plan shares | ( | ) | ( | ) | ||||
| Average number of common shares outstanding used to calculate basic earnings per common share | ||||||||
| Effect of dilutive equity incentive plan | ||||||||
| Effect of dilutive stock options | ||||||||
| Average number of common shares outstanding used to calculate diluted earnings per common share | ||||||||
| Basic earnings per share | $ | $ | ||||||
| Diluted earnings per share | $ | $ | ||||||
7
3. COMPREHENSIVE INCOME (LOSS)
Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities are reported as a separate component of the equity section of the balance sheet, such items, along with net income, are components of comprehensive income (loss).
The components of accumulated other comprehensive loss included in shareholders’ equity are as follows:
| March 31, 2022 | December 31, 2021 | |||||||
| (In thousands) | ||||||||
| Net unrealized losses on available-for-sale securities | $ | ( | ) | $ | ( | ) | ||
| Tax effect | ||||||||
| Net-of-tax amount | ( | ) | ( | ) | ||||
| Unrecognized actuarial loss on the defined benefit plan | ( | ) | ( | ) | ||||
| Tax effect | ||||||||
| Net-of-tax amount | ( | ) | ( | ) | ||||
| Accumulated other comprehensive loss | $ | ( | ) | $ | ( | ) | ||
8
4. INVESTMENT SECURITIES
Available-for-sale and held-to-maturity investment securities at March 31, 2022 and December 31, 2021 are summarized as follows:
| March 31, 2022 | ||||||||||||||||
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
| (In thousands) | ||||||||||||||||
| Available-for-sale securities: | ||||||||||||||||
| Debt securities: | ||||||||||||||||
| Government-sponsored enterprise obligations | $ | $ | $ | ( | ) | $ | ||||||||||
| State and municipal bonds | ||||||||||||||||
| Corporate bonds | ( | ) | ||||||||||||||
| Total debt securities | ( | ) | ||||||||||||||
| Mortgage-backed securities: | ||||||||||||||||
| Government-sponsored mortgage-backed securities | ( | ) | ||||||||||||||
| U.S. government guaranteed mortgage-backed securities | ( | ) | ||||||||||||||
| Total mortgage-backed securities | ( | ) | ||||||||||||||
| Total available-for-sale | ( | ) | ||||||||||||||
| Held-to-maturity securities: | ||||||||||||||||
| Debt securities: | ||||||||||||||||
| U.S. Treasury securities | — | ( | ) | |||||||||||||
| Total debt securities | — | ( | ) | |||||||||||||
| Mortgage-backed securities: | ||||||||||||||||
| Government-sponsored mortgage-backed securities | — | ( | ) | |||||||||||||
| Total mortgage-backed securities | — | ( | ) | |||||||||||||
| Total held-to-maturity | ( | ) | ||||||||||||||
Total | $ | $ | $ | ( | ) | $ | ||||||||||
9
| December 31, 2021 | ||||||||||||||||
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
| (In thousands) | ||||||||||||||||
| Available-for-sale securities: | ||||||||||||||||
| Debt securities: | ||||||||||||||||
| Government-sponsored enterprise obligations | $ | $ | $ | ( | ) | $ | ||||||||||
| State and municipal bonds | ||||||||||||||||
| Corporate bonds | ||||||||||||||||
| Total debt securities | ( | ) | ||||||||||||||
| Mortgage-backed securities: | ||||||||||||||||
| Government-sponsored mortgage-backed securities | ( | ) | ||||||||||||||
| U.S. government guaranteed mortgage-backed securities | ( | ) | ||||||||||||||
| Total mortgage-backed securities | ( | ) | ||||||||||||||
| Total available-for-sale | ( | ) | ||||||||||||||
| Held-to-maturity securities: | ||||||||||||||||
| Debt securities: | ||||||||||||||||
| U.S. Treasury securities | — | ( | ) | |||||||||||||
| Total debt securities | — | ( | ) | |||||||||||||
| Mortgage-backed securities: | ||||||||||||||||
| Government-sponsored mortgage-backed securities | — | ( | ) | |||||||||||||
| Total mortgage-backed securities | — | ( | ) | |||||||||||||
| Total held-to-maturity | — | ( | ) | |||||||||||||
Total | $ | $ | $ | ( | ) | $ | ||||||||||
At
March 31, 2022, U.S. Treasury securities with a fair value of $
The amortized cost and fair value of available-for-sale and held-to-maturity securities at March 31, 2022, by final maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers have the right to call or prepay obligations.
| Available-for-Sale | Held-to-Maturity | |||||||||||||||
| Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||
| (In thousands) | ||||||||||||||||
| Debt securities: | ||||||||||||||||
| Due after one year through five years | $ | $ | $ | $ | ||||||||||||
| Due after five years through ten years | ||||||||||||||||
| Due after ten years | ||||||||||||||||
| Total debt securities | ||||||||||||||||
| Mortgage-backed securities: | ||||||||||||||||
| Due after five years through ten years | ||||||||||||||||
| Due after ten years | ||||||||||||||||
| Total mortgage-backed securities | ||||||||||||||||
| Total securities | $ | $ | $ | $ | ||||||||||||
10
Gross realized gains and losses on sales of available-for-sale securities for the three months ended March 31, 2022 and 2021 are as follows:
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2022 | 2021 | |||||||
| (In thousands) | ||||||||
| Gross gains realized | $ | $ | ||||||
| Gross losses realized | ( | ) | ( | ) | ||||
| Net loss realized | $ | ( | ) | $ | ( | ) | ||
Proceeds
from the sales and redemption of available-for-sale securities totaled $
Information pertaining to securities with gross unrealized losses at March 31, 2022 and December 31, 2021, aggregated by investment category and length of time that individual securities have been in a continuous loss position are as follows:
| March 31, 2022 | ||||||||||||||||||||||||||||||||
| Less Than Twelve Months | Over Twelve Months | |||||||||||||||||||||||||||||||
| Number of Securities | Fair Value | Gross Unrealized Loss | Depreciation from Amortized Cost Basis (%) | Number of Securities | Fair Value | Gross Unrealized Loss | Depreciation from Amortized Cost Basis (%) | |||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Available-for-sale: | ||||||||||||||||||||||||||||||||
| Government-sponsored mortgage-backed securities | $ | $ | % | $ | $ | % | ||||||||||||||||||||||||||
| U.S. government guaranteed mortgage-backed securities | ||||||||||||||||||||||||||||||||
| Government-sponsored enterprise obligations | ||||||||||||||||||||||||||||||||
| Corporate Bonds | ||||||||||||||||||||||||||||||||
| Total available-for-sale | ||||||||||||||||||||||||||||||||
| Held-to-maturity: | ||||||||||||||||||||||||||||||||
| U.S. Treasury securities | % | % | ||||||||||||||||||||||||||||||
| Government-sponsored mortgage-backed securities | ||||||||||||||||||||||||||||||||
| Total held-to-maturity | ||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||||||||||||||||||
11
| December 31, 2021 | ||||||||||||||||||||||||||||||||
| Less Than Twelve Months | Over Twelve Months | |||||||||||||||||||||||||||||||
| Number of Securities | Fair Value | Gross Unrealized Loss | Depreciation from Amortized Cost Basis (%) | Number of Securities | Fair Value | Gross Unrealized Loss | Depreciation from Amortized Cost Basis (%) | |||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Available-for-sale: | ||||||||||||||||||||||||||||||||
| Government-sponsored mortgage-backed securities | $ | $ | % | $ | $ | % | ||||||||||||||||||||||||||
| U.S. government guaranteed mortgage-backed securities | ||||||||||||||||||||||||||||||||
| Government-sponsored enterprise obligations | ||||||||||||||||||||||||||||||||
| Total available-for-sale | ||||||||||||||||||||||||||||||||
| Held-to-maturity: | ||||||||||||||||||||||||||||||||
| U.S. Treasury securities | % | % | ||||||||||||||||||||||||||||||
| Government-sponsored mortgage-backed securities | ||||||||||||||||||||||||||||||||
| Total held-to-maturity | ||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||||||||||||||||||
During the three months ended March 31, 2022 and year ended December 31, 2021, the Company did not record any other-than-temporary impairment (“OTTI”) charges on its investments. Management regularly reviews the portfolio for securities with unrealized losses. Management attributed the unrealized losses at March 31, 2022 to increases in current market yields compared to the yields at the time the investments were purchased by the Company and not due to credit quality.
The process for assessing investments for OTTI may vary depending on the type of security. In assessing the Company's investments in government-sponsored and U.S. government guaranteed mortgage-backed securities and government-sponsored enterprise obligations, the contractual cash flows of these investments are guaranteed by the respective government-sponsored enterprise; Federal Home Loan Mortgage Corporation (“FHLMC”), Federal National Mortgage Association (“FNMA”), Federal Farm Credit Bank (“FFCB”), or Federal Home Loan Bank (“FHLB”). Accordingly, it is expected that the securities would not be settled at a price less than the par value of the Company's investments. Management's assessment of other debt securities within the portfolio includes reviews of market pricing, ongoing credit quality evaluations, assessment of the investments' materiality, and duration of the investments' unrealized loss position. At March 31, 2022, the Company's corporate and municipal bond portfolios did not contain any securities rated below investment grade, as reported by major credit rating agencies.
12
5. LOANS AND ALLOWANCE FOR LOAN LOSSES
Major classifications of loans at the periods indicated were as follows:
| March 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| (In thousands) | ||||||||
| Commercial real estate | $ | $ | ||||||
| Residential real estate: | ||||||||
| Residential one-to-four family | ||||||||
| Home equity | ||||||||
| Total residential real estate | ||||||||
| Commercial and industrial: | ||||||||
| Paycheck Protection Program (“PPP”) loans | ||||||||
| Commercial and industrial | ||||||||
| Total commercial and industrial | ||||||||
| Consumer | ||||||||
| Total gross loans | ||||||||
| Unamortized PPP loan fees | ( | ) | ( | ) | ||||
| Unearned premiums and deferred loan fees and costs, net | ||||||||
| Total loans, net | ||||||||
| Allowance for loan losses | ( | ) | ( | ) | ||||
| Net loans | $ | $ | ||||||
Loans Serviced for Others.
The
Company has transferred a portion of its originated commercial loans to participating lenders. The amounts transferred have been
accounted for as sales and are therefore not included in our accompanying consolidated balance sheets. We continue to service
the loans on behalf of the participating lenders. We share with participating lenders, on a pro-rata basis, any gains or losses
that may result from a borrower’s lack of compliance with contractual terms of the loan. At March 31, 2022 and December
31, 2021, the Company was servicing commercial loans participated out to various other institutions totaling $
Residential
real estate mortgages are originated by the Bank both for its portfolio and for sale into the secondary market. The Bank may sell
its loans to institutional investors such as the FHLMC. Under loan sale and servicing agreements with the investor, the Bank generally
continues to service the residential real estate mortgages. The Bank pays the investor an agreed upon rate on the loan, which
is less than the interest rate received from the borrower. The Bank retains the difference as a fee for servicing the residential
real estate mortgages. The Bank capitalizes mortgage servicing rights at their fair value upon sale of the related loans, amortizes
the asset over the estimated life of the serviced loan, and periodically assesses the asset for impairment. The significant assumptions
used by a third party to estimate the fair value of capitalized servicing rights at March 31, 2022, include weighted average prepayment
speed for the portfolio using the Public Securities Association Standard Prepayment Model (
At
March 31, 2022 and December 31, 2021, the Company was servicing residential mortgage loans owned by investors totaling $
13
A summary of the activity in the balances of mortgage servicing rights follows:
| Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| (In thousands) | ||||||||
| Balance at the beginning of year: | $ | $ | ||||||
| Capitalized mortgage servicing rights | ||||||||
| Amortization | ( | ) | ( | ) | ||||
| Balance at the end of period | $ | $ | ||||||
| Fair value at the end of period | $ | $ | ||||||
Loans are recorded at the principal amount outstanding, adjusted for charge-offs, unearned premiums and deferred loan fees and costs. Interest on loans is calculated using the effective yield method on daily balances of the principal amount outstanding and is credited to income on the accrual basis to the extent it is deemed collectable. Our general policy is to discontinue the accrual of interest when principal or interest payments are delinquent 90 days or more based on the contractual terms of the loan, or earlier if the loan is considered impaired. Any unpaid amounts previously accrued on these loans are reversed from income. Subsequent cash receipts are applied to the outstanding principal balance or to interest income if, in the judgment of management, collection of the principal balance is not in question. Loans are returned to accrual status when they become current as to both principal and interest and perform in accordance with contractual terms for a period of at least six months, reducing the concern as to the collectability of principal and interest. Loan fees and certain direct loan origination costs are deferred, and the net fee or cost is recognized as an adjustment to interest income over the estimated average lives of the related loans.
The allowance for loan losses is established through provisions for loan losses charged to expense. Loans are charged-off against the allowance when management believes that the collectability of the principal is unlikely. Subsequent recoveries, if any, are credited to the allowance.
The allowance for loan losses is evaluated on a regular basis by management. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. The allowance consists of general, allocated, and unallocated components, as further described below.
General component
The general component of the allowance for loan losses is based on historical loss experience adjusted for qualitative factors stratified by the following loan segments: residential real estate (includes one-to-four family and home equity), commercial real estate, commercial and industrial, and consumer. Management uses a rolling average of historical losses based on a time frame appropriate to capture relevant loss data for each loan segment. This historical loss factor is adjusted for the following qualitative factors: trends in delinquencies and nonperforming loans; trends in volume and terms of loans; effects of changes in risk selection and underwriting standards and other changes in lending policies, procedures and practices; and national and local economic trends and industry conditions. There were no changes to the Company’s policies and procedures surrounding the allowance for loan losses during the three months ended March 31, 2022. In addition, during the year ended December 31, 2020, the Company determined that it was prudent to provide an allowance for loan losses related to the loan portfolio acquired on October 24, 2016 from Chicopee Bancorp, Inc. (“Chicopee”) due to the ongoing impacts and extended nature of the pandemic.
The qualitative factors are determined based on the various risk characteristics of each loan segment. Risk characteristics relevant to each portfolio segment are as follows:
Residential
real estate. We require private mortgage insurance for all loans originated with a loan-to-value ratio greater than
14
Commercial real estate. Loans in this segment are primarily income-producing investment properties and owner-occupied commercial properties throughout New England. The underlying cash flows generated by the properties or operations can be adversely impacted by a downturn in the economy due to increased vacancy rates or diminished cash flows, which in turn, would have an effect on the credit quality in this segment. Management obtains financial information annually and continually monitors the cash flows of these loans.
Commercial and industrial loans. Loans in this segment are made to businesses and are generally secured by assets of the business. Repayment is expected from the cash flows of the business. A weakened economy, and resultant decreased consumer spending, will have an effect on the credit quality in this segment.
Consumer loans. Loans in this segment are secured or unsecured and repayment is dependent on the credit quality of the individual borrower.
Allocated component
The allocated component relates to loans that are classified as impaired. Impaired loans are identified by analysis of loan performance, internal credit ratings and watch list loans that management believes are subject to a higher risk of loss. Impairment is measured on a loan by loan basis for commercial real estate and commercial and industrial loans by either the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. An allowance is established when the discounted cash flows (or collateral value) of the impaired loan is lower than the carrying value of that loan. Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, we do not separately identify individual consumer and residential real estate loans for impairment disclosures, unless such loans are subject to a troubled debt restructuring agreement.
A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. We determine the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed.
Unallocated component
An unallocated component may be maintained to cover uncertainties that could affect management’s estimate of probable losses. The unallocated component of the allowance, if any, reflects the margin of imprecision inherent in the underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio.
15
An analysis of changes in the allowance for loan losses by segment for the three months ended March 31, 2022 and 2021 is as follows:
| Commercial Real Estate | Residential Real Estate | Commercial and Industrial | Consumer | Unallocated | Total | |||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||
| Balance at December 31, 2020 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Provision (credit) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
| Charge-offs | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
| Recoveries | ||||||||||||||||||||||||
| Balance at March 31, 2021 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Balance at December 31, 2021 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Provision (credit) | ( | ) | ( | ) | ||||||||||||||||||||
| Charge-offs | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Recoveries | ||||||||||||||||||||||||
| Balance at March 31, 2022 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
The following table presents information pertaining to the allowance for loan losses by segment, excluding PPP loans, for the dates indicated:
| Commercial Real Estate | Residential Real Estate | Commercial and Industrial | Consumer | Unallocated | Total | |||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||
| March 31, 2022 | ||||||||||||||||||||||||
| Amount of allowance for impaired loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Amount of allowance for non-impaired loans | ||||||||||||||||||||||||
| Total allowance for loan losses | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Impaired loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Non-impaired loans | ||||||||||||||||||||||||
| Impaired loans acquired with deteriorated credit quality | ||||||||||||||||||||||||
| Total loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| December 31, 2021 | ||||||||||||||||||||||||
| Amount of allowance for impaired loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Amount of allowance for non-impaired loans | ||||||||||||||||||||||||
| Total allowance for loan losses | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Impaired loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Non-impaired loans | ||||||||||||||||||||||||
| Impaired loans acquired with deteriorated credit quality | ||||||||||||||||||||||||
| Total loans | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
16
Past Due and Nonaccrual Loans.
The following tables present an age analysis of past due loans, excluding PPP loans, as of the dates indicated:
| 30 – 59 Days Past Due | 60 – 89 Days Past Due | 90 Days or More Past Due | Total Past Due Loans | Total Current Loans | Total Loans | Nonaccrual Loans | ||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||||||
| March 31, 2022 | ||||||||||||||||||||||||||||
| Commercial real estate | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
| Residential real estate: | ||||||||||||||||||||||||||||
| Residential | ||||||||||||||||||||||||||||
| Home equity | ||||||||||||||||||||||||||||
| Commercial and industrial | ||||||||||||||||||||||||||||
| Consumer | ||||||||||||||||||||||||||||
Total loans | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
| December 31, 2021 | ||||||||||||||||||||||||||||
| Commercial real estate | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
| Residential real estate: | ||||||||||||||||||||||||||||
| Residential | ||||||||||||||||||||||||||||
| Home equity | ||||||||||||||||||||||||||||
| Commercial and industrial | ||||||||||||||||||||||||||||
| Consumer | ||||||||||||||||||||||||||||
| Total loans | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Impaired Loans.
The following is a summary of impaired loans by class:
| Three Months Ended | ||||||||||||||||||||
| At March 31, 2022 | March 31, 2022 | |||||||||||||||||||
| Recorded Investment | Unpaid Principal Balance | Related Allowance | Average Recorded Investment | Interest Income Recognized | ||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| Impaired Loans (1) | ||||||||||||||||||||
| Commercial real estate | $ | $ | $ | — | $ | $ | ||||||||||||||
| Residential real estate: | ||||||||||||||||||||
| Residential real estate | — | |||||||||||||||||||
| Home equity | — | |||||||||||||||||||
| Commercial and industrial | — | |||||||||||||||||||
| Consumer | — | |||||||||||||||||||
| Total impaired loans | $ | $ | $ | — | $ | $ | ||||||||||||||
17
| Three Months Ended | ||||||||||||||||||||
| At December 31, 2021 | March 31, 2021 | |||||||||||||||||||
| Recorded Investment | Unpaid Principal Balance | Related Allowance | Average Recorded Investment | Interest Income Recognized | ||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| Impaired Loans (1) | ||||||||||||||||||||
| Commercial real estate | $ | $ | $ | — | $ | $ | ||||||||||||||
| Residential rea estate: | ||||||||||||||||||||
| Residential real estate | — | |||||||||||||||||||
| Home equity | — | |||||||||||||||||||
| Commercial and industrial | — | |||||||||||||||||||
| Consumer | — | — | ||||||||||||||||||
| Total impaired loans | $ | $ | $ | — | $ | $ | ||||||||||||||
| (1) |
With the exception of loans acquired with deteriorated credit quality, the majority of impaired loans are included within the nonaccrual balances; however, not every loan on nonaccrual status has been designated as impaired. Impaired loans include loans that have been modified in a troubled debt restructuring (“TDR”). Impaired loans are individually evaluated and exclude large groups of smaller-balance homogeneous loans, such as residential mortgage loans and consumer loans, which are collectively evaluated for impairment, and loans that are measured at fair value, unless the loan is amended in a TDR.
All payments received on impaired loans in nonaccrual status are applied to principal. There was no interest income recognized on nonaccrual impaired loans during the three months ended March 31, 2022 and March 31, 2021. The Company's obligation to fulfill the additional funding commitments on impaired loans is generally contingent on the borrower's compliance with the terms of the credit agreement. If the borrower is not in compliance, additional funding commitments may or may not be made at the Company's discretion. At March 31, 2022 and 2021, we had not committed to lend any additional funds for loans that are classified as impaired. Payments received on impaired loans in accrual status are recorded in accordance with the contractual terms of the loan. Interest income recognized on impaired loans during the three months ended March 31, 2022 and 2021 pertained to performing TDRs and purchased impaired loans.
Troubled Debt Restructurings.
Loans are designated as a TDR when, as part of an agreement to modify the original contractual terms of the loan as a result of financial difficulties of the borrower, the Bank grants the borrower a concession on the terms that would not otherwise be considered. Typically, such concessions may consist of a reduction in interest rate to a below market rate, taking into account the credit quality of the note, extension of additional credit based on receipt of adequate collateral, or a deferment or reduction of payments (principal or interest) which materially alters the Bank's position or significantly extends the note's maturity date, such that the present value of cash flows to be received is materially less than those contractually established at the loan's origination. All loans that are modified are reviewed by the Company to identify if a TDR has occurred. All TDR loans are classified as impaired.
When we modify loans in a TDR, we measure impairment similar to other impaired loans based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or use the current fair value of the collateral, less selling costs for collateral dependent loans. If we determine that the value of the modified loan is less than the recorded investment in the loan (net of previous charge-offs, deferred loan fees or costs and unamortized premium or discount), impairment is recognized through a specific allowance or a charge-off to the allowance. Nonperforming TDRs are included in nonperforming loans.
There were no loan modifications classified as TDRs during the three months ended March 31, 2022 and 2021. During the three months ended March 31, 2022 and 2021, no TDRs defaulted (defined as 30 days or more past due) within 12 months of restructuring. There were no charge-offs on TDRs during the three months ended March 31, 2022 or 2021.
18
Loans Acquired with Deteriorated Credit Quality.
The following is a summary of loans acquired with deteriorated credit quality in the Chicopee acquisition.
| Contractual Required Payments Receivable | Cash Expected To Be Collected | Non- Accretable Discount | Accretable Yield | Loans Receivable | |||||||||||||||||
| (In thousands) | |||||||||||||||||||||
| Balance at December 31, 2021 | $ | $ | $ | $ | $ | ||||||||||||||||
| Collections | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
| Dispositions | ( | ) | ( | ) | ( | ) | |||||||||||||||
| Balance at March 31, 2022 | $ | $ | $ | $ | $ | ||||||||||||||||
Credit Quality Information.
The Company utilizes an eight-grade internal loan rating system for commercial real estate and commercial and industrial loans. Performing residential real estate, home equity and consumer loans are grouped with “Pass” rated loans. Nonperforming residential real estate, home equity and consumer loans are monitored individually for impairment and risk rated as “substandard.”
Loans rated 1 – 4: Loans rated 1-4 represent groups of loans that are not subject to adverse criticism as defined in regulatory guidance. Loans in these groups exhibit characteristics that represent acceptable risk.
Loans rated 5: Loans rated 5 are considered “Special Mention” and may exhibit potential credit weaknesses or downward trends and are being monitored by management. Loans in this category are currently protected based on collateral and repayment capacity and do not constitute undesirable credit risk, but have potential weakness that may result in deterioration of the repayment process at some future date. This classification is used if a negative trend is evident in the obligor’s financial situation. Special mention loans do not sufficiently expose the Company to warrant adverse classification.
Loans rated 6: Loans rated 6 are considered “Substandard.” A loan is classified as substandard if the borrower exhibits a well-defined weakness and may be inadequately protected by the current net worth and cash flow capacity to pay the current debt.
Loans rated 7: Loans rated 7 are considered “Doubtful.” Loans classified as doubtful have all the weaknesses inherent in those classified substandard with the added characteristic that the weaknesses make collection or liquidation of the loan highly questionable and improbable. The possibility of some loss is extremely high, but because of specific pending factors that may work to the advantage and strengthening of the asset, its classification as an estimated loss is deferred until its more exact status may be determined.
Loans rated 8: Loans rated 8 are considered uncollectible. The loss classification does not mean that the asset has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off the asset because recovery and collection time may be affected in the future.
On an annual basis, or more often if needed, we formally review the ratings on all commercial real estate and commercial and industrial loans. In addition, management utilizes delinquency reports, the criticized loan report and other loan reports to monitor credit quality. In addition, at least on an annual basis, the Company contracts with an external loan review company to review the internal credit ratings assigned to loans in the commercial loan portfolio on a pre-determined schedule, based on the type, size, rating, and overall risk of the loan. During the course of its review, the third party examines a sample of loans, including new loans, existing relationships over certain dollar amounts and classified assets.
19
The following table presents our loans by risk rating for the periods indicated:
| Commercial Real Estate | Residential 1-4 Family | Home Equity | Commercial and Industrial | Consumer | Total | |||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||
| March 31, 2022 | ||||||||||||||||||||||||
| Pass (Rated 1 – 4) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Special Mention (Rated 5) | ||||||||||||||||||||||||
| Substandard (Rated 6) | ||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| December 31, 2021 | ||||||||||||||||||||||||
| Pass (Rated 1 – 4) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Special Mention (Rated 5) | ||||||||||||||||||||||||
| Substandard (Rated 6) | ||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ |
6. GOODWILL AND OTHER INTANGIBLES
Goodwill.
At March 31, 2022 and December 31, 2021, the Company’s goodwill was related to the acquisition of Chicopee in October 2016. There was no goodwill impairment recorded during the three months ended March 31, 2022 or the year ended December 31, 2021. Annually, or more frequently if events or changes in circumstances warrant such evaluation, the Company evaluates its goodwill for impairment.
Core Deposit Intangible.
In
connection with the acquisition of Chicopee, the Bank recorded a core deposit intangible of $
Stock Options.
A summary of stock option activity for the three months ended March 31, 2022 is presented below:
| Shares | Weighted Average Exercise Price | Weighted (in years) | Aggregate (in thousands) | ||||||||||||||
| Outstanding at December 31, 2021 | $ | $ | |||||||||||||||
| Exercised | ( | ) | |||||||||||||||
| Outstanding at March 31, 2022 | $ | $ | |||||||||||||||
| Exercisable at March 31, 2022 | $ | $ | |||||||||||||||
Cash
received for options exercised during the three months ended March 31, 2022 and 2021 was $
20
Restricted Stock Awards.
In May 2014, the Company’s shareholders approved the 2014 Omnibus Incentive Plan, a stock-based compensation plan (the “2014 RSA Plan”). Under the 2014 RSA Plan, up to shares of the Company’s common stock were reserved for grants of stock awards, including stock options and restricted stock, which may be granted to any officer, key employee or non-employee director of WNEB. Any shares that are not issued because vesting requirements are not met were available for future issuance under the 2014 RSA Plan.
On an annual basis, the Compensation Committee (the “Committee”) approves long-term incentive awards out of the 2014 RSA Plan, whereby shares will be granted to eligible participants of the Company that are nominated by the Chief Executive Officer and approved by the Committee, with vesting over a -year term for employees and a -year term for directors. Annual employee grants provide for a periodic award that is both performance and time-based and is designed to recognize the executive’s responsibilities, reward performance and leadership and as a retention tool. The objective of the award is to align compensation for the named executive officers and directors over a multi-year period directly with the interests of our shareholders by motivating and rewarding creation and preservation of long-term financial strength, shareholder value and relative shareholder return.
In February 2019, shares were granted. Of the 108,718 shares, shares were time-based, with vesting in and vesting ratably over a -year period. The remaining shares granted are performance-based and are subject to the achievement of the 2019 long-term incentive performance metric. The primary performance metric for 2019 grants was return on equity. Performance shares will be earned based upon how the Company performs relative to threshold, target and maximum absolute goals (i.e. Company-specific, not relative to a peer index) on an annual performance period, but will be distributed at the end of the -year period.
The threshold, target and stretch metrics under the 2019 grants are as follows:
| Return on Equity Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| December 31, 2019 | % | % | % | ||||||||||
| December 31, 2020 | % | % | % | ||||||||||
| December 31, 2021 | % | % | % | ||||||||||
Eligible participants will be able to earn between % (“threshold” performance), % (“target” performance) and % (“maximum” performance). As of December 31, 2021, the three-year performance period for the 2019 grants ended. The 2019 long term incentive plan included a “catch-up” provision allowing unearned performance-based shares from the 2019 and 2020 performance periods to be earned at the end of the three-year period based on the final year performance. Of the original performance-based shares granted in 2019, shares were eligible for vesting based on achieving target. Because of the “catch-up” provision within the plan, performance-based shares vested and were issued to eligible recipients in February 2022 based on achieving stretch for each performance period.
In February 2020, shares were granted. Of the shares, shares were time-based, with vesting in and vesting ratably over a -year period. The remaining shares granted are performance-based and are subject to the achievement of the 2020 long-term incentive performance metrics, with % of the performance-based shares vesting for each performance metric. The primary performance metrics for the 2020 grants are return on equity and earnings per share. Performance shares will be earned based upon how the Company performs relative to threshold, target and maximum absolute goals (i.e. Company-specific, not relative to a peer index) on an annual performance period for return on equity metrics and for a -year cumulative performance period for earnings per share, but will be distributed at the end of the -year period as earned.
21
The threshold, target and stretch metrics under the 2020 grants are as follows:
| Return on Equity Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| December 31, 2020 | % | % | % | ||||||||||
| December 31, 2021 | % | % | % | ||||||||||
| December 31, 2022 | % | % | % | ||||||||||
| Earnings Per Share Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| Three-year Cumulative Diluted Earnings Per Share | $ | $ | $ | ||||||||||
Eligible participants will be able to earn between % (“threshold” performance), % (“target” performance) and % (“maximum” performance).
The fair market value of shares awarded is based on the market price at the grant date, recorded as unearned compensation and amortized over the applicable vesting period. Performance-based metrics are monitored on a quarterly basis in order to compare actual results to the performance metric, with any necessary adjustments being recognized through share-based compensation expense and unearned compensation.
In February 2021, shares were granted to our directors, with a -year vesting period. At December 31, 2021, there were no remaining shares available to grant under the 2014 RSA Plan.
In May 2021, the Company’s shareholders approved the 2021 Omnibus Incentive Plan, a stock-based compensation plan (the “2021 RSA Plan”). Under the 2021 RSA Plan, up to shares of the Company’s common stock were reserved for grants of stock awards, including stock options and restricted stock, which may be granted to any officer, key employee or non-employee director of the Company. Any shares that are not issued because vesting requirements are not met will be available for future issuance under the 2021 RSA Plan.
In May 2021, shares were granted. Of the shares, shares were time-based, vesting ratably over a -year period. The remaining shares granted are performance-based and are subject to the achievement of the 2021 long-term incentive performance metrics, with % of the performance-based shares vesting for each performance metric. The primary performance metrics for the 2021 grants are return on equity and earnings per share. Performance shares will be earned based upon how the Company performs relative to threshold, target and maximum absolute goals (i.e. Company-specific, not relative to a peer index) on an annual performance period for return on equity metrics and for a -year cumulative performance period for earnings per share, but will be distributed at the end of the -year period as earned.
The threshold, target and stretch metrics under the 2021 grants are as follows:
| Return on Equity Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| December 31, 2021 | % | % | % | ||||||||||
| December 31, 2022 | % | % | % | ||||||||||
| December 31, 2023 | % | % | % | ||||||||||
| Earnings Per Share Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| Three-year Cumulative Diluted Earnings Per Share | $ | $ | $ | ||||||||||
22
In March 2022, shares were granted. Of the shares, shares were time-based, with vesting in and vesting ratably over a -year period. The remaining shares granted are performance-based and are subject to the achievement of the 2022 long-term incentive performance metrics, with % of the performance-based shares vesting for each performance metric. The primary performance metrics for the 2022 grants are return on equity and earnings per share. Performance shares will be earned based upon how the Company performs relative to threshold, target and maximum absolute goals (i.e. Company-specific, not relative to a peer index) on an annual performance period for return on equity metrics and for a -year cumulative performance period for earnings per share, but will be distributed at the end of the -year period as earned.
The threshold, target and stretch metrics under the 2022 grants are as follows:
| Return on Equity Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| December 31, 2022 | % | % | % | ||||||||||
| December 31, 2023 | % | % | % | ||||||||||
| December 31, 2024 | % | % | % | ||||||||||
| Earnings Per Share Metrics | |||||||||||||
| Performance Period Ending | Threshold | Target | Stretch | ||||||||||
| Three-year Cumulative Diluted Earnings Per Share | $ | $ | $ | ||||||||||
At March 31, 2022, there were remaining shares available to grant under the 2021 RSA Plan.
| Shares | Weighted Average Grant Date Fair Value | ||||||||
| Balance at December 31, 2021 | $ | ||||||||
| Shares granted | |||||||||
| Shares forfeited | ( | ) | |||||||
| Shares vested | ( | ) | |||||||
| Balance at March 31, 2022 | $ | ||||||||
| Shares | Weighted Average Grant Date Fair Value | ||||||||
| Balance at December 31, 2020 | $ | ||||||||
| Shares granted | |||||||||
| Shares forfeited | ( | ) | |||||||
| Shares vested | ( | ) | |||||||
| Balance at March 31, 2021 | $ | ||||||||
We
recorded total expense for restricted stock awards of $
8. SHORT-TERM BORROWINGS AND LONG-TERM DEBT
Total borrowing capacity includes borrowing arrangements at the FHLB, the Federal Reserve Bank (“FRB”), and borrowing arrangements with correspondent banks.
The
Company is a member of the FHLB and uses borrowings as an additional source of funding to finance the Company’s lending
and investing activities and to provide liquidity for daily operations. FHLB advances also provide more pricing and option alternatives
for particular asset/liability needs. The FHLB provides a central credit facility primarily for member institutions. As an FHLB
member, the Company is required to own capital stock of the FHLB, calculated periodically based primarily on its level of borrowings
from the FHLB. FHLB borrowings are secured by certain securities from the Company’s investment portfolio not otherwise pledged
as well as certain residential real estate and commercial real estate loans. Advances are made under several different credit
programs with different lending standards, interest rates and range of maturities. This relationship is an integral component
of the Company’s asset-liability management program. At March 31, 2022, the Bank had $
23
The
Company also has an available overnight Ideal Way line of credit with the FHLB of $
The
Company has an available line of credit of $
The
Company also has pre-established, non-collateralized overnight borrowing arrangements with large national and regional correspondent
banks to provide additional overnight and short-term borrowing capacity for the Company. The Company has a $
Long-term
debt consists of FHLB advances with an original maturity of one year or more. At March 31, 2022, we had $
9. SUBORDINATED DEBT
On
April 20, 2021, the Company completed an offering of $
Unless
earlier redeemed, the Notes mature on
The
Notes are presented net of issuance costs of $
10. PENSION BENEFITS
We
provide a defined benefit pension plan for eligible employees (the “Plan”). Employees must work a minimum of
24
The following table provides information regarding net pension benefit costs for the periods shown:
Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| (In thousands) | ||||||||
| Service cost | $ | $ | ||||||
| Interest cost | ||||||||
| Expected return on assets | ( | ) | ( | ) | ||||
| Amortization of actuarial loss | ||||||||
| Net periodic pension cost | $ | $ | ||||||
11. DERIVATIVES AND HEDGING ACTIVITIES
Risk Management Objective of Using Derivatives.
The Company is exposed to certain risks arising from both our business operations and economic conditions. We principally manage our exposures to a wide variety of business and operational risks through management of our core business activities. We manage economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of our assets and liabilities and the use of derivative financial instruments. Specifically, we entered into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. Our derivative financial instruments are used to manage differences in the amount, timing, and duration of our known or expected cash receipts and our known or expected cash payments principally related to certain variable rate loan assets and variable rate borrowings.
The following table presents information about interest rate swaps at March 31, 2022 and December 31, 2021:
| March 31, 2022 | Notional | Weighted Average | Weighted Average Rate | Fair | ||||||||||||||||
| Amount | Maturity | Receive | Pay | Value | ||||||||||||||||
| (In thousands) | (In years) | (In thousands) | ||||||||||||||||||
| Non-hedging derivatives: | ||||||||||||||||||||
| Loan-level swaps – dealer counterparties | $ | % | % | $ | ||||||||||||||||
| Loan-level swaps – borrower counterparties | % | % | ( | ) | ||||||||||||||||
| Forward starting loan-level swaps - dealer counterparties | ||||||||||||||||||||
| Forward starting loan-level swaps - borrower counterparties | ( | ) | ||||||||||||||||||
| Total | $ | $ | ||||||||||||||||||
| December 31, 2021 | Notional | Weighted Average | Weighted Average Rate | Fair | ||||||||||||||||
| Amount | Maturity | Receive | Pay | Value | ||||||||||||||||
| (In thousands) | (In years) | (In thousands) | ||||||||||||||||||
| Non-hedging derivatives: | ||||||||||||||||||||
| Loan-level swaps – dealer counterparties | $ | % | % | $ | ( | ) | ||||||||||||||
| Loan-level swaps – borrower counterparties | % | % | ||||||||||||||||||
| Forward starting loan-level swaps - dealer counterparties | ||||||||||||||||||||
| Forward starting loan-level swaps - borrower counterparties | ( | ) | ||||||||||||||||||
| Total | $ | $ | ||||||||||||||||||
25
Cash Flow Hedges of Interest Rate Risk.
The Company’s objectives in using interest rate derivatives are to add stability to interest income and expense and to manage its exposure to interest rate movements. To accomplish these objectives, we entered into interest rate swaps as part of our interest rate risk management strategy. These interest rate swaps are designated as cash flow hedges and involve the receipt of variable rate amounts from a counterparty in exchange for our making fixed payments.
For derivatives designated as cash flow hedges, the changes in the fair value of the derivative is initially reported in other comprehensive income (outside of earnings), net of tax, and subsequently reclassified to earnings when the hedged transaction affects earnings. We are hedging our exposure to the variability in future cash flows for forecasted transactions over a maximum period of six years (excluding forecasted payment of variable interest on existing financial instruments).
Non-hedging Derivatives.
Derivatives not designated as hedges are not speculative, but rather result from a service the Company provides to certain customers. The Company executes loan level derivative products such as interest-rate swap agreements with commercial banking customers to aid them in managing their interest-rate risk by converting floating-rate loan payments to fixed-rate loan payments. The Company concurrently enters into offsetting swaps with a third party financial institution, effectively minimizing its net risk exposure resulting from such transactions. The third-party financial institution exchanges the customer's fixed-rate loan payments for floating-rate loan payments. As the interest-rate swap agreements associated with this program do not meet hedge accounting requirements, changes in the fair value are recognized directly in earnings.
Fair Values of Derivative Instruments on the Balance Sheet.
The table below presents the fair value of our derivative financial instruments not designated as hedging instruments as well as our classification on the balance sheet as of March 31, 2022 and December 31, 2021.
| March 31, 2022 | Asset Derivatives | Liability Derivatives | |||||||||
| Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||
| (In thousands) | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||
| Interest rate swap – with borrower counterparties | $ | $ | |||||||||
| Interest rate swap – with dealer counterparties | |||||||||||
| Total derivatives not designated as hedging instruments | Other Assets | $ | Other Liabilities | $ | |||||||
| December 31, 2021 | Asset Derivatives | Liability Derivatives | |||||||||
| Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||
| (In thousands) | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||
| Interest rate swap – with borrower counterparties | $ | $ | |||||||||
| Interest rate swap – with dealer counterparties | |||||||||||
| Total derivatives not designated as hedging instruments | Other Assets | $ | Other Liabilities | $ | |||||||
26
Effect of Derivative Instruments in the Consolidated Statements of Net Income and Changes in Shareholders’ Equity.
There were gains or losses recognized in accumulated other comprehensive income during the three months ended March 31, 2021 or 2020.
Amounts reported in accumulated other comprehensive loss related to cash flow hedge derivatives are reclassified to interest expense as interest payments are made on our designated rate sensitive liabilities. The table below presents the amount reclassified from accumulated other comprehensive loss into net income for interest rate swaps and termination fees:
| Amount of Loss Reclassified from OCI into Expense (Effective Portion) | ||||||||
| Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Interest rate swaps | $ | $ | ||||||
As of December 31, 2021, the Company no longer has any outstanding cash flow hedges.
Credit-risk-related Contingent Features
By using derivative financial instruments, we expose ourselves to credit risk. Credit risk is the risk of failure by the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk for us. When the fair value of a derivative is negative, we owe the counterparty and, therefore, it does not possess credit risk. The credit risk in derivative instruments is mitigated by entering into transactions with highly-rated counterparties that we believe to be creditworthy and by limiting the amount of exposure to each counterparty.
We have agreements with our derivative counterparties that contain a provision where if we default on any of our indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then we could also be declared in default on our derivative obligations. We also have agreements with certain of our derivative counterparties that contain a provision where if we fail to maintain our status as well capitalized, then the counterparty could terminate the derivative positions and we would be required to settle our obligations under the agreements. Certain of our agreements with our derivative counterparties contain provisions where if a formal administrative action by a federal or state regulatory agency occurs that materially changes our creditworthiness in an adverse manner, we may be required to fully collateralize our obligations under the derivative instrument.
At March 31, 2022, we had minimum collateral posting thresholds with certain of our derivative counterparties. As of March 31, 2022, we were not required to post collateral under these agreements because we did not have any derivatives in a liability position with those counterparties.
12. FAIR VALUE OF ASSETS AND LIABILITIES
Determination of Fair Value.
We use fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for our various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument.
27
Fair Value Hierarchy.
We group our assets and liabilities that are measured at fair value in three levels, based on the markets in which the assets are traded and the reliability of the assumptions used to determine fair value.
Level 1: Valuation is based on quoted prices in active markets for identical assets. Level 1 assets generally include debt and equity securities that are traded in an active exchange market. Valuations are obtained from readily available pricing sources for market transactions involving identical assets.
Level 2: Valuation is based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3: Valuation is based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets. Level 3 assets include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.
Methods and assumptions for valuing our financial instruments measured at fair value on a recurring basis are set forth below. Estimated fair values are calculated based on the value without regard to any premium or discount that may result from concentrations of ownership of a financial instrument, possible tax ramifications or estimated transaction cost.
Securities Available-for-Sale.
The securities measured at fair value in Level 1 are based on quoted market prices in an active exchange market. These securities include marketable equity securities and U.S. Treasury securities. All other securities are measured at fair value in Level 2 and are based on pricing models that consider standard input factors such as observable market data, benchmark yields, interest rate volatilities, broker/dealer quotes, credit spreads and new issue data. These securities include government-sponsored enterprise obligations, state and municipal obligations, residential mortgage-backed securities guaranteed and sponsored by the U.S. government or an agency thereof. Fair value measurements are obtained from a third-party pricing service and are not adjusted by management.
Interest Rate Swaps.
The valuation of our interest rate swaps is obtained from a third-party pricing service and is determined using a discounted cash flow analysis on the expected cash flows of each derivative. The pricing analysis is based on observable inputs for the contractual terms of the derivatives, including the period to maturity and interest rate curves. We have determined that the majority of the inputs used to value our interest rate derivatives fall within Level 2 of the fair value hierarchy.
Assets and Liabilities Measured at Fair Value on a Recurring Basis.
Assets and liabilities measured at fair value on a recurring basis are summarized below:
| March 31, 2022 | ||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | (In thousands) | |||||||||||||||
| Securities available-for-sale | $ | $ | $ | $ | ||||||||||||
| Marketable equity securities | ||||||||||||||||
| Interest rate swaps | ||||||||||||||||
| Total assets | $ | $ | $ | $ | ||||||||||||
| Liabilities: | ||||||||||||||||
| Interest rate swaps | $ | $ | $ | $ | ||||||||||||
28
| December 31, 2021 | ||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Assets: | (In thousands) | |||||||||||||||
| Securities available-for-sale | $ | $ | $ | $ | ||||||||||||
| Marketable equity securities | ||||||||||||||||
| Interest rate swaps | ||||||||||||||||
| Total assets | $ | $ | $ | $ | ||||||||||||
| Liabilities: | ||||||||||||||||
| Interest rate swaps | $ | $ | $ | $ | ||||||||||||
Assets Measured at Fair Value on a Non-recurring Basis.
We may also be required, from time to time, to measure certain other assets at fair value on a non-recurring basis in accordance with U.S. GAAP. These adjustments to fair value usually result from application of lower-of-cost-or-market accounting or write-downs of individual assets. There were no assets measured at fair value on a non-recurring basis at March 31, 2022 or 2021.
Summary of Fair Values of Financial Instruments.
The estimated fair values of our financial instruments are as follows:
| March 31, 2022 | ||||||||||||||||||||
| Carrying Value | Fair Value | |||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | |||||||||||||||
| Securities held-to-maturity | ||||||||||||||||||||
| Securities available-for-sale | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Federal Home Loan Bank of Boston and other restricted stock | ||||||||||||||||||||
| Loans - net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Derivative asset | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
29
| December 31, 2021 | ||||||||||||||||||||
| Carrying Value | Fair Value | |||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | |||||||||||||||
| Securities held-to-maturity | ||||||||||||||||||||
| Securities available-for-sale | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Federal Home Loan Bank of Boston and other restricted stock | ||||||||||||||||||||
| Loans - net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Derivative asset | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| ||||||||||||||||||||
13. RECENT ACCOUNTING PRONOUNCEMENTS
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The ASU also requires enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the financial statements. This ASU, as amended, is effective for the Company in fiscal years beginning after December 15, 2022. The Company is in the process of implementing the standard. We have put together a project team that has begun to identify appropriate loan segments along with related historical losses for each segment and potential models that would be most appropriate for each individual segment. We have not quantified the effects of any models, but do expect the standard to significantly change the approach to calculating our allowance for loan losses.
30
ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Overview.
We strive to remain a leader in meeting the financial service needs of the local community and to provide quality service to the individuals and businesses in the market areas that we have served since 1853. Historically, we have been a community-oriented provider of traditional banking products and services to business organizations and individuals, including products such as residential and commercial real estate loans, commercial and industrial loans, consumer loans and a variety of deposit products. We meet the needs of our local community through a community-based and service-oriented approach to banking.
We have adopted a growth-oriented strategy that continues to focus on increasing commercial lending and residential lending. Our strategy also calls for increasing deposit relationships, specifically core deposits, and broadening our product lines and services. We believe that this business strategy is best for our long-term success and viability, and complements our existing commitment to high-quality customer service.
In connection with our overall growth strategy, we seek to:
| ● | Grow the Company’s commercial loan portfolio and related commercial deposits by targeting businesses in our primary market area of Hampden County and Hampshire County in western Massachusetts and Hartford and Tolland Counties in northern Connecticut to increase the net interest margin and loan income; |
| ● | Supplement the commercial portfolio by growing the residential real estate portfolio to diversify the loan portfolio and deepen customer relationships; |
| ● | Focus on expanding our retail banking deposit franchise and increase the number of households served within our designated market area; |
| ● | Invest in people, systems and technology to grow revenue, improve efficiency and enhance the overall customer experience; |
| ● | Grow revenues, increase book value and tangible book value per share, continue to pay competitive dividends to shareholders and utilize the Company’s stock repurchase plan to leverage our capital and enhance franchise value; and |
| ● | Consider growth through acquisitions. We may pursue expansion opportunities in existing or adjacent strategic locations with companies that add complementary products to our existing business and at terms that add value to our existing shareholders. |
You should read the following financial results for the three months ended March 31, 2022 in the context of this strategy.
| ● | Net income was $5.3 million, or $0.24 per diluted share, for the three months ended March 31, 2022, compared to $5.8 million, or $0.24 per diluted share, for the same period in 2021. |
| ● | The provision for loan losses decreased $500,000, from a provision for loan losses of $75,000 for the three months ended March 31, 2021 to a credit for loan losses of $425,000 for the three months ended March 31, 2022. The Company recorded net charge-offs of $54,000 for the three months ended March 31, 2022, as compared to net charge-offs of $5,000 for the three months ended March 31, 2021. The decrease in the provision versus comparative periods reflects management’s current assessment of the impact of the COVID-19 pandemic on the Bank’s loan portfolio. |
| ● | Net interest income increased $672,000, or 3.7%, to $18.7 million, for the three months ended March 31, 2022, from $18.0 million for the three months ended March 31, 2021. The increase in net interest income was due to a decrease in interest expense of $762,000, or 38.0%, primary due to a $742,000, or 42.8%, decrease in interest expense on deposits. |
31
CRITICAL ACCOUNTING POLICIES.
Our consolidated financial statements are prepared in accordance with U.S. GAAP and practices within the banking industry. Application of these principles requires management to make estimates, assumptions, and judgments that affect the amounts reported in the financial statements and accompanying notes. These estimates, assumptions, and judgments are based on information available as of the date of the financial statements; accordingly, as this information changes, the financial statements could reflect different estimates, assumptions, and judgments. Actual results could differ from those estimates.
Critical accounting estimates are necessary in the application of certain accounting policies and procedures, and are particularly susceptible to significant change. Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and could potentially result in materially different results under different assumptions and conditions. There have been no material changes to our critical accounting policies during the three months ended March 31, 2022. For additional information on our critical accounting policies, please refer to the information contained in Note 1 of the accompanying unaudited consolidated financial statements and Note 1 of the consolidated financial statements included in our 2021 Annual Report.
RECENT DEVELOPMENTS: CORONAVIRUS PANDEMIC RESPONSE AND ACTIONS.
The Company continues to monitor COVID-19’s impact on its business and customers, however, the extent to which COVID-19 will continue to impact its results and operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact, and the direct and indirect economic effects of the pandemic and containment measures.
Our business is dependent upon the willingness and ability of our employees and customers to conduct banking and other financial transactions. The COVID-19 global public health crisis and the resulting “stay-at-home” orders resulted in widespread volatility, severe disruptions in the U.S. economy at large, and for small businesses in particular, deterioration in household, business, economic and market conditions.
Paycheck Protection Program.
As a Preferred Lender with the Small Business Administration (“SBA”), the Company was in a position to react quickly to the PPP component of the March 27, 2020 $2.2 trillion fiscal stimulus bill known as the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) launched by the U.S. Department of the Treasury and the SBA. An eligible business was able to apply for a PPP loan up to the lesser of: (1) 2.5 times its average monthly “payroll costs,” or (2) $10.0 million. PPP loans have: (a) an interest rate of 1.0%, (b) a two-year loan term to maturity, subsequently extended to a five-year loan term maturity for loans granted on or after June 5, 2020 and (c) principal and interest payments deferred from six months to ten months from the date of disbursement. The SBA will guarantee 100% of the PPP loans made to eligible borrowers. The entire principal amount of the borrower’s PPP loan, including any accrued interest, is eligible to be reduced by the loan forgiveness amount under the PPP so long as employee and compensation levels of the business are maintained and 60% of the loan proceeds are used for payroll expenses, with the remaining 40% of the loan proceeds used for other qualifying expenses. As of March 31, 2022, the Company received funding approval from the SBA for 2,146 applications totaling $302.2 million. As of March 31, 2022, the Company processed 2,093 PPP loan forgiveness applications totaling $296.1 million. Total PPP loans decreased $19.3 million, or 76.3%, from $25.3 million at December 31, 2021 to $6.1 million at March 31, 2022.
During the three months ended March 31, 2022, the Company recognized $562,000 in PPP income, compared to $2.4 million during the three months ended March 31, 2021. As of March 31, 2022, the Company had $255,000 in remaining deferred PPP loan processing fees.
32
The table below breaks out the PPP income recognized for the periods noted:
| For the Three Months Ended | ||||||||||||||||||||
| March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | ||||||||||||||||
| ($ in thousands) | ||||||||||||||||||||
| PPP origination fee income | $ | 526 | $ | 868 | $ | 1,556 | $ | 1,240 | $ | 1,999 | ||||||||||
| PPP interest income | 36 | 105 | 201 | 387 | 412 | |||||||||||||||
| Total PPP Income | $ | 562 | $ | 973 | $ | 1,757 | $ | 1,627 | $ | 2,411 | ||||||||||
Loan Modifications/Troubled Debt Restructurings.
The banking regulatory agencies, through an Interagency Statement dated April 7, 2020, have encouraged financial institutions to work “prudently” with borrowers who request loan modifications or deferrals as a result of the economic impacts of COVID-19. Pursuant to Section 4013 of the CARES Act, loans less than 30 days past due as of December 31, 2019 will be considered current for COVID-19 modifications. Financial institutions can then suspend the requirements under U.S. GAAP for loan modifications related to COVID-19 that would otherwise be categorized as a TDR, and suspend any determination of a loan modified as a result of COVID-19 as being a TDR, including the requirement to determine impairment for accounting under U.S. GAAP. The Company has adopted this policy election to address COVID-19 loan modification requests that have been received from the earlier of either January 1, 2022 or the 60th day after the end of the COVID-19 national emergency.
The Company implemented a modification deferral program under the CARES Act, which allowed residential, commercial and consumer borrowers who were adversely affected by the COVID-19 pandemic, to defer loan payments for a set period of time. As of March 31, 2022, the Company had two remaining commercial real estate loans, with an outstanding principal balance of $12.1 million, under CARES Act modification. The two borrowers were granted a principal deferral under the Company’s modification deferral program, but continue to make their interest and real estate tax payments. There were no outstanding deferrals related to residential and consumer loans under CARES modification as of March 31, 2022.
Allowance for Loan Losses.
In determining the allowance for loan losses, the Company considers quantitative loss factors and a number of qualitative factors, such as underwriting policies, current economic conditions, delinquency statistics, the adequacy of the underlying collateral and the financial strength of the borrower. The ongoing COVID-19 pandemic could cause us to experience higher credit losses in our lending portfolio, reduce demand for our products and services and other negative impacts on our financial position, results of operations and prospects. As of March 31, 2022, the Company’s delinquency and nonperforming assets have not been materially impacted by the COVID-19 pandemic, and therefore, have not resulted in material credit losses within the lending portfolio.
The Company is continuing to monitor COVID-19’s impact on its business and its customers, however, the extent to which COVID-19 will further impact its results and operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact and the direct and indirect economic effects of the pandemic and containment measures.
COMPARISON OF FINANCIAL CONDITION AT MARCH 31, 2022 AND DECEMBER 31, 2021
At March 31, 2022, total assets were $2.6 billion, an increase of $17.0 million, or 0.7%, from December 31, 2021. During the three months ended March 31, 2022, cash and cash equivalents decreased $40.6 million, or 39.2%, to $62.9 million, investment securities decreased $5.4 million, or 1.3%, to $423.1 million and total loans, excluding PPP loans, increased $80.8 million, or 4.4%, to $1.9 billion.
At March 31, 2022, the Company’s available-for-sale securities portfolio decreased $20.4 million, or 10.5%, from $194.4 million at December 31, 2021 to $173.9 million at March 31, 2022. The held-to-maturity securities portfolio, recorded at amortized cost, increased $15.3 million, or 6.9%, from $222.3 million at December 31, 2021 to $237.6 million at March 31, 2022. The Company allocated a portion of its excess liquidity to the investment portfolio as an alternative to cash and cash equivalents. This shift from overnight investments to held-to-maturity securities will assist the Company with managing the yield on interest-earning assets in the low interest rate environment that we are experiencing while providing ongoing cash flows from payments and pay downs. The primary objective of the investment portfolio is to provide liquidity and maximize income while preserving the safety of principal.
33
At March 31, 2022, total loans were $1.9 billion, an increase of $61.6 million, or 3.3%, from December 31, 2021. Excluding PPP loans, total loans increased $80.8 million, or 4.4%, driven by an increase in commercial real estate loans of $59.5 million, or 6.1%, partially offset by a decrease in total commercial and industrial loans of $10.7 million, or 4.7%. Excluding a decrease of $19.3 million in PPP loans from December 31, 2021, commercial and industrial loans increased $8.6 million, or 4.2%, at March 31, 2022. Residential real estate loans, which include home equity loans, increased $12.4 million, or 1.9%. In accordance with the Company’s asset/liability management strategy, during the three months ended March 31, 2022, the Company sold $277,000 of fixed rate, low coupon residential real estate loans to the secondary market. As of March 31, 2022, the Company serviced $85.5 million in loans sold to the secondary market, compared to $88.2 million at December 31, 2021. Servicing rights will continue to be retained on all loans written and sold to the secondary market.
All loans where the payments are 90 days or more in arrears as of the closing date of each month are placed on nonaccrual status. If all nonaccrual loans had been performing in accordance with their terms, we would have earned additional interest income of $60,000 and $80,000 for the three months ended March 31, 2022 and 2021, respectively.
At March 31, 2022, nonperforming loans totaled $4.0 million, or 0.21% of total loans, compared to $5.0 million, or 0.27% of total loans, at December 31, 2021. At March 31, 2022, there were no loans 90 or more days past due and still accruing interest. Nonperforming assets to total assets, was 0.16% at March 31, 2022, compared to 0.20% at December 31, 2021. The allowance for loan losses as a percentage of total loans, was 1.00% at March 31, 2022, compared to 1.06% at December 31, 2021. At March 31, 2022, the allowance for loan losses as a percentage of nonperforming loans was 484.2%, compared to 398.6%, at December 31, 2021. A summary of our past due and nonaccrual loans by class are listed in Note 5 of the accompanying unaudited consolidated financial statements.
At March 31, 2022, total deposits were $2.3 billion, an increase of $21.3 million, or 0.9%, from December 31, 2021, primarily due to an increase in core deposits of $44.2 million, or 2.4%. Core deposits, which the Company defines as all deposits except time deposits, increased to $1.9 billion and were 83.4% and 82.2% of total deposits at March 31, 2022 and December 31, 2021, respectively. Non-interest-bearing deposits decreased $11.1 million, or 1.7%, to $630.2 million, interest-bearing checking accounts decreased $6.4 million, or 4.4%, to $139.3 million, savings accounts increased $7.0 million, or 3.2%, to $224.6 million, and money market accounts increased $54.7 million, or 6.4%, to $905.1 million. Time deposits decreased $23.0 million, or 5.7%, from $402.0 million at December 31, 2021 to $379.0 million at March 31, 2022. The Company did not have any brokered deposits at March 31, 2022 or December 31, 2021.
At March 31, 2022, total borrowings decreased $1.0 million, or 4.5%, from $22.3 million at December 31, 2021, to $21.3 million. FHLB advances decreased $1.0 million, or 36.5%, to $1.7 million and subordinated debt outstanding totaled $19.6 million at March 31, 2022 and at December 31, 2021.
At March 31, 2022, shareholders’ equity was $219.1 million, or 8.6% of total assets, compared to $223.7 million, or 8.8% of total assets, at December 31, 2021. The decrease in shareholders’ equity reflects $1.2 million for the repurchase of the Company’s common stock, the payment of regular cash dividends of $1.3 million and an increase in accumulated other comprehensive loss of $8.4 million, partially offset by net income of $5.3 million. Total shares outstanding as of March 31, 2022 were 22,742,189.
The Company’s book value per share was $9.63 at March 31, 2022 compared to $9.87 at December 31, 2021, while tangible book value per share, a non-GAAP financial measurement, decreased $0.24, or 2.6%, from $9.21 at December 31, 2021 to $8.97 at March 31, 2022. AOCI reduced the tangible book value per common share by $0.37 as of March 31, 2022, primarily due to the impact of higher interest rates on the fair value of available-for-sale securities. As of March 31, 2022, the Company’s and the Bank’s regulatory capital ratios continued to exceed the levels required to be considered “well-capitalized” under federal banking regulations. See “Explanation of Use of Non-GAAP Financial Measurements” for more information regarding our uses of non-GAAP financial measurements.
34
The Company’s regulatory capital ratios remain in compliance with regulatory “well capitalized” requirements and internal target minimal levels. At March 31, 2022, the Company’s Tier 1 leverage, common equity tier 1 capital, and total risk-based capital ratios were 8.9%, 11.9%, and 14.0%, respectively, and the Bank’s Tier 1 leverage, common equity tier 1 capital, and total risk-based capital ratios were 9.1%, 12.1%, and 13.1%, respectively, compared with regulatory “well capitalized” minimums of 5.00%, 6.5%, and 10.00%, respectively.
COMPARISON OF OPERATING RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND MARCH 31, 2021
General.
Net income was $5.3 million, or $0.24 per diluted share, for the three months ended March 31, 2022, compared to $5.8 million, or $0.24 per diluted share, for the same period in 2021. Net interest income was $18.7 million and $18.0 million for the three months ended March 31, 2022 and 2021, respectively.
Net Interest and Dividend Income.
The following tables set forth the information relating to our average balance and net interest income for the three months ended March 31, 2022 and 2021, and reflect the average yield on interest-earning assets and average cost of interest-bearing liabilities for the periods indicated. Yields and costs are derived by dividing annualized interest income by the average balance of interest-earning assets and annualized interest expense by the average balance of interest-bearing liabilities for the periods shown. The interest rate spread is the difference between the total average yield on interest-earning assets and the cost of interest-bearing liabilities. Net interest margin represents tax-equivalent net interest and dividend income as a percentage of average interest-earning assets. Average balances are derived from actual daily balances over the periods indicated. Interest income includes fees earned when the real estate loans are prepaid or refinanced. For analytical purposes, the interest earned on tax-exempt assets is adjusted to a tax-equivalent basis to recognize the income tax savings which facilitates comparison between taxable and tax-exempt assets.
35
| Three Months Ended March 31, | ||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||
| Average | Average Yield/ | Average | Average Yield/ | |||||||||||||||||||||
| Balance | Interest | Cost | Balance | Interest | Cost | |||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||
| ASSETS: | ||||||||||||||||||||||||
| Interest-earning assets | ||||||||||||||||||||||||
| Loans(1)(2) | $ | 1,894,870 | $ | 18,067 | 3.87 | % | $ | 1,923,477 | $ | 19,220 | 4.05 | % | ||||||||||||
| Securities(2) | 423,437 | 1,950 | 1.87 | 227,330 | 854 | 1.52 | ||||||||||||||||||
| Other investments - at cost | 10,595 | 25 | 0.96 | 9,663 | 35 | 1.47 | ||||||||||||||||||
| Short-term investments(3) | 57,030 | 21 | 0.15 | 95,004 | 24 | 0.10 | ||||||||||||||||||
| Total interest-earning assets | 2,385,932 | 20,063 | 3.41 | 2,255,474 | 20,133 | 3.62 | ||||||||||||||||||
| Total non-interest-earning assets | 143,635 | 144,588 | ||||||||||||||||||||||
| Total assets | $ | 2,529,567 | $ | 2,400,062 | ||||||||||||||||||||
| LIABILITIES AND EQUITY: | ||||||||||||||||||||||||
| Interest-bearing liabilities | ||||||||||||||||||||||||
| Interest-bearing checking accounts | $ | 132,192 | 95 | 0.29 | % | $ | 90,503 | $ | 105 | 0.47 | % | |||||||||||||
| Savings accounts | 218,448 | 36 | 0.07 | 187,217 | 37 | 0.08 | ||||||||||||||||||
| Money market accounts | 878,393 | 521 | 0.24 | 675,662 | 653 | 0.39 | ||||||||||||||||||
| Time deposits | 389,063 | 340 | 0.35 | 567,102 | 939 | 0.67 | ||||||||||||||||||
| Total interest-bearing deposits | 1,618,096 | 992 | 0.25 | 1,520,484 | 1,734 | 0.46 | ||||||||||||||||||
| Short-term borrowings and long-term debt | 21,975 | 253 | 4.67 | 52,670 | 273 | 2.10 | ||||||||||||||||||
| Interest-bearing liabilities | 1,640,071 | 1,245 | 0.31 | 1,573,154 | 2,007 | 0.52 | ||||||||||||||||||
| Non-interest-bearing deposits | 633,082 | 561,581 | ||||||||||||||||||||||
| Other non-interest-bearing liabilities | 32,857 | 38,360 | ||||||||||||||||||||||
| Total non-interest-bearing liabilities | 665,939 | 599,941 | ||||||||||||||||||||||
| Total liabilities | 2,306,010 | 2,173,095 | ||||||||||||||||||||||
| Total equity | 223,557 | 226,967 | ||||||||||||||||||||||
| Total liabilities and equity | $ | 2,529,567 | $ | 2,400,062 | ||||||||||||||||||||
| Less: Tax-equivalent adjustment(2) | (120 | ) | (100 | ) | ||||||||||||||||||||
| Net interest and dividend income | $ | 18,698 | $ | 18,026 | ||||||||||||||||||||
| Net interest rate spread(4) | 3.08 | % | 3.08 | % | ||||||||||||||||||||
| Net interest rate spread, on a tax equivalent basis(5) | 3.10 | % | 3.10 | % | ||||||||||||||||||||
| Net interest margin(6) | 3.18 | % | 3.24 | % | ||||||||||||||||||||
| Net interest margin, on a tax equivalent basis(7) | 3.20 | % | 3.26 | % | ||||||||||||||||||||
| Ratio of average interest-earning assets to average interest-bearing liabilities | 145.48 | % | 143.37 | % | ||||||||||||||||||||
| (1) | Loans, including nonaccrual loans, are net of deferred loan origination costs and unadvanced funds. |
| (2) | Loan and securities income are presented on a tax-equivalent basis using a tax rate of 21%. The tax-equivalent adjustment is deducted from tax-equivalent net interest and dividend income to agree to the amount reported on the consolidated statements of net income. |
| (3) | Short-term investments include federal funds sold. |
| (4) | Net interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average cost of interest-bearing liabilities. |
| (5) | Net interest rate spread, on a tax-equivalent basis, represents the difference between the tax-equivalent weighted average yield on interest-earning assets and the tax-equivalent weighted average cost of interest-bearing liabilities. |
| (6) | Net interest margin represents net interest and dividend income as a percentage of average interest-earning assets. |
| (7) | Net interest margin, on a tax-equivalent basis, represents tax-equivalent net interest and dividend income as a percentage of average interest-earning assets. See “Explanation of Use of Non-GAAP Financial Measurements”. |
36
Rate/Volume Analysis.
The following table shows how changes in interest rates and changes in the volume of interest-earning assets and interest-bearing liabilities have affected our interest and dividend income and interest expense during the periods indicated. Information is provided in each category with respect to: (1) interest income changes attributable to changes in volume (changes in volume multiplied by prior rate); (2) interest income changes attributable to changes in rate (changes in rate multiplied by prior volume); and (3) the net change.
The changes attributable to the combined impact of volume and rate have been allocated proportionately to the changes due to volume and the changes due to rate.
| Three Months Ended March 31, 2022 compared to Three Months Ended March 31, 2021 | ||||||||||||
| Increase (Decrease) Due to | ||||||||||||
| Volume | Rate | Net | ||||||||||
| Interest-earning assets | (In thousands) | |||||||||||
| Loans (1) | $ | (286 | ) | $ | (867 | ) | $ | (1,153 | ) | |||
| Securities (1) | 737 | 359 | 1,096 | |||||||||
| Other investments - at cost | 3 | (13 | ) | (10 | ) | |||||||
| Short-term investments | (10 | ) | 7 | (3 | ) | |||||||
| Total interest-earning assets | 444 | (514 | ) | (70 | ) | |||||||
| Interest-bearing liabilities | ||||||||||||
| Interest-bearing checking accounts | 48 | (58 | ) | (10 | ) | |||||||
| Savings accounts | 6 | (7 | ) | (1 | ) | |||||||
| Money market accounts | 196 | (328 | ) | (132 | ) | |||||||
| Time deposits | (295 | ) | (304 | ) | (599 | ) | ||||||
| Short-term borrowing and long-time debt | (159 | ) | 139 | (20 | ) | |||||||
| Total interest-bearing liabilities | (204 | ) | (558 | ) | (762 | ) | ||||||
| Change in net interest and dividend income (1) | $ | 648 | $ | 44 | $ | 692 | ||||||
| (1) | Securities, loan income and change in net interest and dividend income are presented on a tax-equivalent basis using a tax rate of 21%. The tax-equivalent adjustment is deducted from tax-equivalent net interest income. |
Net interest income increased $672,000, or 3.7%, to $18.7 million for the three months ended March 31, 2022, from $18.0 million for the three months ended March 31, 2021. The increase in net interest income was due to a decrease in interest expense of $762,000, or 38.0%, primary due to a $742,000, or 42.8%, decrease in interest expense on deposits. Excluding PPP income, interest income increased $1.8 million, or 10.0%, from the three months ended March 31, 2021 to the three months ended March 31, 2022 primarily due to higher investment and loan income.
Net interest income for the three months ended March 31, 2022 included PPP income of $562,000, compared to $2.4 million for the three months ended March 31, 2021. During the three months ended March 31, 2022 interest income included $39,000 in positive purchase accounting adjustments, compared to $45,000 in negative purchase accounting adjustments during the three months ended March 31, 2021. Net interest income as adjusted for the preceding items increased $2.4 million, or 15.6%, from $15.7 million during the three months ended March 31, 2021, to $18.1 million during the three months ended March 31, 2022.
The net interest margin was 3.18% for the three months ended March 31, 2022, compared to 3.24%, for the three months ended March 31, 2021. The net interest margin, on a tax-equivalent basis, was 3.20% for the three months ended March 31, 2022, compared to 3.26% for the three months ended March 31, 2021. Excluding the adjustments discussed above, the net interest margin increased six basis points from 3.04% for the three months ended March 31, 2021 to 3.10% for the three months ended March 31, 2022. The Company’s net interest margin was positively impacted by higher average balances for loans and securities and a decrease in lower yielding interest-earning assets.
37
The loan yield decreased 19 basis points from 4.03% for the three months ended March 31, 2021 to 3.84% for the three months ended March 31, 2022. Excluding PPP loans and purchase accounting adjustments, the average loan yield decreased 13 basis points from 3.87% for the three months ended March 31, 2021 to 3.74% for the three months ended March 31, 2022. The average yield on interest-earning assets decreased 21 basis points from 3.60% for the three months ended March 31, 2021 to 3.39% for the three months ended March 31, 2022.
During the three months ended March 31, 2022, average interest-earning assets increased $130.5 million, or 5.8%, to $2.4 billion compared to the three months ended March 31, 2021. The increase was primarily due to an increase in average securities of $197.0 million, or 83.1%. Excluding the $151 million decrease in average PPP loans, average loans increased $122.9 million, or 7.0%, from the three months ended March 31, 2021 to the three months ended March 31, 2022. Total average loans, excluding average PPP loans, were 78.8% of total average interest-earning assets for the three months ended March 31, 2022, compared to 77.9% for the three months ended March 31, 2021.
During the three months ended March 31, 2022, the average cost of funds, including non-interest bearing demand accounts and borrowings, decreased 16 basis points, from 0.38% for the three months ended March 31, 2021 to 0.22% for the three months ended March 31, 2022. The average cost of core deposits, including non-interest bearing demand deposits, decreased 7 basis points from 0.21% for the three months ended March 31, 2021 to 0.14% for the three months ended March 31, 2022. The average cost of time deposits decreased 32 basis points from 0.67% for the three months ended March 31, 2021 to 0.35% for the three months ended March 31, 2022, while the average cost of borrowings increased from 2.10% for the three months ended March 31, 2021 to 4.67% for the three months ended March 31, 2022. Average demand deposits, an interest-free source of funds, increased $71.5 million, or 12.7%, from $561.6 million, or 27.0% of total average deposits, for the three months ended March 31, 2021 to $633.1 million, or 28.1%, of total average deposits, for the three months ended March 31, 2022.
Provision for Loan Losses.
The provision for loan losses is reviewed by management based upon our evaluation of then-existing economic and business conditions affecting our key lending areas and other conditions, such as new loan products, credit quality trends (including trends in nonperforming loans expected to result from existing conditions), collateral values, loan volumes and concentrations, specific industry conditions within portfolio segments that existed as of the balance sheet date and the impact that such conditions were believed to have had on the collectability of the loan portfolio.
The provision for loan losses decreased $500,000, from a provision for loan losses of $75,000 for the three months ended March 31, 2021 to a credit for loan losses of $425,000 for the three months ended March 31, 2022. The Company recorded net charge-offs of $54,000 for the three months ended March 31, 2022, as compared to net charge-offs of $5,000 for the three months ended March 31, 2021. The decrease in the provision versus comparative periods reflected management’s current assessment of the impact of the COVID-19 pandemic on the Bank’s loan portfolio. Management continues to assess the exposure of the Company’s loan portfolio to the COVID-19 pandemic, economic trends and their potential effect on asset quality. As of March 31, 2022, the Company’s delinquencies and nonperforming assets had not been materially impacted by the COVID-19 pandemic.
Although we believe that we have established and maintained the allowance for loan losses at adequate levels, future adjustments may be necessary if economic, real estate and other conditions differ substantially from the current operating environment. If the COVID-19 pandemic has an adverse effect on the ability of our borrowers to satisfy their obligations to us, the demand for our loans or our other products and services, other aspects of our business operations, or on financial markets, real estate markets, or economic growth, this could, depending on the extent of the loan defaults, materially and adversely affect our liquidity and financial condition and our results of operations could be materially and adversely affected.
Non-Interest Income.
Non-interest income decreased $656,000, or 21.8%, to $2.3 million for the three months ended March 31, 2022, from $3.0 million for the three months ended March 31, 2021. The three months ended March 31, 2021, included a gain on non-marketable equity investments of $546,000. Service charges and fees on deposits increased $291,000, or 15.5%, and income from bank-owned life insurance increased $7,000, or 1.6%, from $441,000 for the three months ended March 31, 2021 to $448,000, for the three months ended March 31, 2022. Income from mortgage banking activities decreased $225,000, or 99.1%, and other income decreased $54,000. During the three months ended March 31, 2022, unrealized losses on marketable equity securities were $276,000, compared to unrealized losses of $89,000 during the three months ended March 31, 2021. During the three months ended March 31, 2022, the Company reported realized losses on the sale of securities of $4,000, compared to realized losses of $62,000 during the three months ended March 31, 2021.
38
Non-Interest Expense.
For the three months ended March 31, 2022, non-interest expense increased $1.1 million, or 8.5%, to $14.5 million from $13.3 million, for the three months ended March 31, 2021. Salaries and employee benefits expense increased $638,000, or 8.4%, to $8.2 million, primarily due to annual merit increases and benefit costs. Other non-interest expense increased $280,000, or 13.7%, occupancy expense increased $74,000, or 5.7%, furniture and equipment increased $53,000, or 10.8%, professional fees increased $33,000, or 6.1%, advertising expenses increased $61,000, or 18.0%, and data processing related expenses increased $2,000, or 0.3%. FDIC insurance expense decreased $12,000, or 4.0%. The efficiency ratio was 68.7% for the three months ended March 31, 2022, compared to 63.4% for the three months ended March 31, 2021. The adjusted efficiency ratio, a non-GAAP financial measure, was 67.8% for the three months ended March 31, 2022, compared to 64.6% for the three months ended March 31, 2021. The adjusted efficiency ratio is a non-GAAP measure. See “Explanation of Use of Non-GAAP Financial Measurements” for the related efficiency ratio calculation and a reconciliation of GAAP to non-GAAP financial measures.
Income Taxes.
Income tax expense for the three months ended March 31, 2022 was $1.7 million, or an effective tax rate of 24.2%, compared to $1.8 million, or an effective tax rate of 24.1%, for the three months ended March 31, 2021.
Explanation of Use of Non-GAAP Financial Measurements.
We believe that it is common practice in the banking industry to present interest income and related yield information on tax-exempt loans and securities on a tax-equivalent basis, as well as presenting tangible book value per share and adjusted efficiency ratio, and that such information is useful to investors because it facilitates comparisons among financial institutions. However, the adjustment of interest income and yields on tax-exempt loans and securities to a tax-equivalent amount, as well as the presentation of tangible book value per share and adjusted efficiency ratio, may be considered to include financial information that is not in compliance with GAAP. A reconciliation from GAAP to non-GAAP is provided below.
39
| Three Months Ended | ||||||||||||||||||||||||
| March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||
| Average Yield | Average Yield | Average Yield | ||||||||||||||||||||||
| Loans (no tax adjustment) | $ | 17,947 | 3.84 | % | $ | 18,089 | 3.88 | % | $ | 19,120 | 4.03 | % | ||||||||||||
| Tax-equivalent adjustment (1) | 120 | 108 | 100 | |||||||||||||||||||||
| Loans (tax-equivalent basis) | $ | 18,067 | 3.87 | % | $ | 18,197 | 3.90 | % | $ | 19,220 | 4.05 | % | ||||||||||||
| Securities (no tax adjustment) | $ | 1,950 | 1.87 | % | $ | 1,763 | $ | 854 | 1.52 | % | ||||||||||||||
| Tax-equivalent adjustment (1) | — | 1 | — | |||||||||||||||||||||
| Securities (tax-equivalent basis) | $ | 1,950 | 1.87 | % | $ | 1,764 | 1.74 | % | $ | 854 | 1.52 | % | ||||||||||||
| Net interest income (no tax adjustment) | $ | 18,698 | $ | 18,582 | $ | 18,026 | ||||||||||||||||||
| Tax-equivalent adjustment (1) | 120 | 109 | 100 | |||||||||||||||||||||
| Net interest income (tax-equivalent basis) | $ | 18,818 | $ | 18,691 | $ | 18,126 | ||||||||||||||||||
| Interest rate spread (no tax adjustment) | 3.08 | % | 2.97 | % | 3.08 | % | ||||||||||||||||||
| Net interest margin (no tax adjustment) | 3.18 | % | 3.08 | % | 3.24 | % | ||||||||||||||||||
| Net interest margin (tax-equivalent) | 3.20 | % | 3.10 | % | 3.26 | % | ||||||||||||||||||
| Net interest income (no tax adjustment) | $ | 18,698 | $ | 18,582 | $ | 18,026 | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||
| Purchase accounting adjustments | 39 | (31 | ) | (45 | ) | |||||||||||||||||||
| Prepayment penalties and fees | 21 | 21 | 35 | |||||||||||||||||||||
| PPP fee income | 562 | 973 | 2,411 | |||||||||||||||||||||
| Adjusted net interest income (non-GAAP) | $ | 18,076 | $ | 17,619 | $ | 15,625 | ||||||||||||||||||
| Average interest-earning assets | $ | 2,385,932 | $ | 2,394,397 | $ | 2,255,474 | ||||||||||||||||||
| Average interest-earnings asset, excluding average PPP loans | $ | 2,370,852 | $ | 2,352,858 | $ | 2,088,910 | ||||||||||||||||||
| Adjusted net interest margin, excluding purchase accounting adjustments, PPP fee income, prepayment penalties and average PPP loans (non-GAAP) | 3.10 | % | 2.97 | % | 3.04 | % | ||||||||||||||||||
| Book Value per Share (GAAP) | $ | 9.63 | $ | 9.87 | $ | 9.07 | ||||||||||||||||||
| Non-GAAP adjustments: | ||||||||||||||||||||||||
| Goodwill | (0.55 | ) | (0.55 | ) | (0.51 | ) | ||||||||||||||||||
| Core deposit intangible | (0.11 | ) | (0.11 | ) | (0.12 | ) | ||||||||||||||||||
| Tangible Book Value per Share (non-GAAP) | $ | 8.97 | $ | 9.21 | $ | 8.44 | ||||||||||||||||||
| Income Before Income Taxes (GAAP) | $ | 7,015 | $ | 8,215 | $ | 7,628 | ||||||||||||||||||
| (Credit) provision for loan losses | (425 | ) | 300 | 75 | ||||||||||||||||||||
| Income Before Taxes and Provision (non-GAAP) | $ | 6,590 | $ | 8,515 | $ | 7,703 | ||||||||||||||||||
40
| Three Months Ended | ||||||||||||
March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||||
| (Dollars in thousands) | ||||||||||||
| Efficiency Ratio: | ||||||||||||
| Non-interest Expense (GAAP) | $ | 14,456 | $ | 13,923 | $ | 13,327 | ||||||
| Net Interest Income (GAAP) | $ | 18,698 | $ | 18,582 | $ | 18,026 | ||||||
| Non-interest Income (GAAP) | $ | 2,348 | $ | 3,856 | $ | 3,004 | ||||||
| Non-GAAP adjustments: | ||||||||||||
| Bank-owned life insurance death benefit | — | (555 | ) | — | ||||||||
| Loss on securities, net | 4 | — | 62 | |||||||||
| Unrealized loss on marketable equity securities | 276 | 96 | 89 | |||||||||
| Gain on non-marketable equity investments | — | (352 | ) | (546 | ) | |||||||
| Non-interest Income for Adjusted Efficiency Ratio (non-GAAP) | $ | 2,628 | $ | 3,045 | $ | 2,609 | ||||||
| Total Revenue for Adjusted Efficiency Ratio (non-GAAP) | $ | 21,326 | $ | 21,627 | $ | 20,635 | ||||||
| Efficiency Ratio (GAAP) | 68.69 | % | 62.05 | % | 63.37 | % | ||||||
| Adjusted Efficiency Ratio (Non-interest Expense (GAAP)/Total Revenue for Adjusted Efficiency Ratio (non-GAAP)) | 67.79 | % | 64.38 | % | 64.58 | % | ||||||
| (1) | The tax equivalent adjustment is based upon a 21% tax rate. |
Liquidity and Capital Resources.
The term “liquidity” refers to our ability to generate adequate amounts of cash to fund loan originations, loan purchases, deposit withdrawals and operating expenses. Our primary sources of liquidity are deposits, scheduled amortization and prepayments of loan principal and mortgage-backed securities, maturities and calls of investment securities and funds provided by our operations. We also can borrow funds from the FHLB based on eligible collateral of loans and securities. Our material cash commitments include funding loan originations, fulfilling contractual obligations with third-party service providers, maintaining operating leases for certain of our Bank properties and satisfying repayment of our long-term debt obligations.
Primary Sources of Liquidity
At March 31, 2022 and December 31, 2021, outstanding borrowings from the FHLB were $1.7 million and $2.7 million, respectively. At March 31, 2022, we had $464.1 million in available borrowing capacity with the FHLB. We have the ability to increase our borrowing capacity with the FHLB by pledging investment securities or additional loans.
In addition, we have available lines of credit of $15.0 million and $50.0 million with other correspondent banks. Interest rates on these lines are determined and reset on a daily basis by each respective bank. At March 31, 2022 and December 31, 2021, we did not have an outstanding balance under either of these lines of credit. In addition, we may enter into reverse repurchase agreements with approved broker-dealers. Reverse repurchase agreements are agreements that allow us to borrow money using our securities as collateral.
We also have outstanding at any time, a significant number of commitments to extend credit and provide financial guarantees to third parties. These arrangements are subject to strict credit control assessments. Guarantees specify limits to our obligations. Because many commitments and almost all guarantees expire without being funded in whole or in part, the contract amounts are not estimates of future cash flows. We are also obligated under agreements with the FHLB to repay borrowed funds and are obligated under leases for certain of our branches and equipment.
Maturing investment securities are a relatively predictable source of funds. However, deposit flows, calls of securities and prepayments of loans and mortgage-backed securities are strongly influenced by interest rates, general and local economic conditions and competition in the marketplace. These factors reduce the predictability of the timing of these sources of funds.
41
The Company’s primary activities are the origination of commercial real estate loans, commercial and industrial loans and residential real estate loans, as well as and the purchase of mortgage-backed and other investment securities. During the three months ended March 31, 2022 and 2021, we originated $149.4 million and $108.3 million in loans, respectively. We purchased securities totaling $20.6 million for the three months ended March 31, 2022 and $79.8 million for the three months ended March 31, 2021. At March 31, 2022, the Company had approximately $206.8 million in loan commitments and letters of credit to borrowers and approximately $320.8 million in available home equity and other unadvanced lines of credit.
Deposit in flows and out flows are affected by the level of interest rates, the products and interest rates offered by competitors and by other factors. At March 31, 2022, time deposit accounts scheduled to mature within one year totaled $330.7 million. Based on the Company’s deposit retention experience and current pricing strategy, we anticipate that a significant portion of these time deposits will remain on deposit. We monitor our liquidity position frequently and anticipate that it will have sufficient funds to meet our current funding commitments for the next 12 months and beyond.
Material Cash Commitments
The Company entered into a long-term contractual obligation with a vendor for use of its core provider and ancillary services beginning in 2016. Total remaining contractual obligations outstanding with this vendor as of March 31, 2022 were estimated to be $13.1 million, with $4.5 million expected to be paid within one year and the remaining $8.6 million to be paid within the next five years. Further, the Company has operating leases for certain of its banking offices and ATMs. Our leases have remaining lease terms of less than one year to seventeen years, some of which include options to extend the leases for additional five-year terms up to fifteen years. Lease liabilities totaled $10.1 million as of March 31, 2022. Principal payments expected to be made on our lease liabilities during the twelve months ended March 31, 2023 are $1.4 million. The remaining lease liability payments totaled $8.7 million and are expected to be made after March 31, 2023.
In addition, the Company completed an offering of $20 million in aggregate principal amount of its 4.875% fixed-to-floating rate subordinated Notes to certain qualified institutional buyers in a private placement transaction on April 20, 2021. Unless earlier redeemed, the Notes mature on May 1, 2031. The Notes will bear interest from the initial issue date to, but excluding, May 1, 2026, or the earlier redemption date, at a fixed rate of 4.875% per annum, payable quarterly in arrears on May 1, August 1, November 1 and February 1 of each year, beginning August 1, 2021, and from and including May 1, 2026, but excluding the maturity date or earlier redemption date, equal to the benchmark rate, which is the 90-day average secured overnight financing rate, plus 412 basis points, determined on the determination date of the applicable interest period, payable quarterly in arrears on May 1, August 1, November 1 and February 1 of each year. The Company may also redeem the Notes, in whole or in part, on or after May 1, 2026, and at any time upon the occurrence of certain events, subject in each case to the approval of the Board of Governors of the Federal Reserve.
We do not anticipate any material capital expenditures during the calendar year 2022, except in pursuance of the Company’s strategic initiatives. The Company does not have any balloon or other payments due on any long-term obligations or any off-balance sheet items other than the commitments and unused lines of credit noted above.
At March 31, 2022, we exceeded each of the applicable regulatory capital requirements. As of March 31, 2022, the most recent notification from the Office of Comptroller of the Currency categorized the Bank as “well-capitalized” under the regulatory framework for prompt corrective action. To be categorized as “well-capitalized,” the Bank must maintain minimum total risk-based, Tier 1 risk-based, Common Equity Tier 1 risk-based, and Tier 1 leverage ratios as set forth in the following table. There are no conditions or events since that notification that management believes would change our category.
42
| Actual | Minimum For Capital Adequacy Purpose | Minimum To Be Well Capitalized | ||||||||||||||||||||||
| Amount | Ratio | Amount | Ratio | Amount | Ratio | |||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||
| March 31, 2022 | ||||||||||||||||||||||||
| Total Capital (to Risk Weighted Assets): | ||||||||||||||||||||||||
| Consolidated | $ | 264,483 | 13.97 | % | $ | 151,486 | 8.00 | % | N/A | N/A | ||||||||||||||
| Bank | 247,643 | 13.09 | 151,340 | 8.00 | $ | 189,175 | 10.00 | % | ||||||||||||||||
| Tier 1 Capital (to Risk Weighted Assets): | ||||||||||||||||||||||||
| Consolidated | 225,532 | 11.91 | 113,614 | 6.00 | N/A | N/A | ||||||||||||||||||
| Bank | 228,335 | 12.07 | 113,505 | 6.00 | 151,340 | 8.00 | ||||||||||||||||||
| Common Equity Tier 1 Capital (to Risk Weighted Assets) | ||||||||||||||||||||||||
| Consolidated | 225,532 | 11.91 | 85,211 | 4.50 | N/A | N/A | ||||||||||||||||||
| Bank | 228,335 | 12.07 | 85,129 | 4.50 | 122,964 | 6.50 | ||||||||||||||||||
| Tier 1 Leverage Ratio (to Adjusted Average Assets): | ||||||||||||||||||||||||
| Consolidated | 225,532 | 8.94 | 100,931 | 4.00 | N/A | N/A | ||||||||||||||||||
| Bank | 228,335 | 9.07 | 100,720 | 4.00 | 125,900 | 5.00 | ||||||||||||||||||
| December 31, 2021 | ||||||||||||||||||||||||
| Total Capital (to Risk Weighted Assets): | ||||||||||||||||||||||||
| Consolidated | $ | 261,093 | 14.27 | % | $ | 146,347 | 8.00 | % | N/A | N/A | ||||||||||||||
| Bank | 243,788 | 13.35 | 146,135 | 8.00 | $ | 182,669 | 10.00 | % | ||||||||||||||||
| Tier 1 Capital (to Risk Weighted Assets): | ||||||||||||||||||||||||
| Consolidated | 221,673 | 12.12 | 109,761 | 6.00 | N/A | N/A | ||||||||||||||||||
| Bank | 224,001 | 12.26 | 109,601 | 6.00 | 146,135 | 8.00 | ||||||||||||||||||
| Common Equity Tier 1 Capital (to Risk Weighted Assets): | ||||||||||||||||||||||||
| Consolidated | 221,673 | 12.12 | 82,320 | 4.50 | N/A | N/A | ||||||||||||||||||
| Bank | 224,001 | 12.26 | 82,201 | 4.50 | 118,735 | 6.50 | ||||||||||||||||||
| Tier 1 Leverage Ratio (to Adjusted Average Assets): | ||||||||||||||||||||||||
| Consolidated | 221,673 | 8.75 | 101,320 | 4.00 | N/A | N/A | ||||||||||||||||||
| Bank | 224,001 | 8.86 | 101,101 | 4.00 | 126,377 | 5.00 | ||||||||||||||||||
We also have outstanding, at any time, a significant number of commitments to extend credit and provide financial guarantees to third parties. These arrangements are subject to strict credit control assessments. Guarantees specify limits to our obligations. Because many commitments and almost all guarantees expire without being funded in whole or in part, the contract amounts are not estimates of future cash flows.
OFF-BALANCE SHEET ARRANGEMENTS.
The Company does not have any off-balance sheet arrangements, other than noted above under Material Cash Commitments, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes in our assessment of our sensitivity to market risk since our presentation in our 2021 Annual Report. Please refer to Item 7A of the 2021 Annual Report for additional information.
43
ITEM 4: CONTROLS AND PROCEDURES
Disclosure Controls and Procedures.
Management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of the end of the period covered by this report. Based upon the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective, to ensure that information required to be disclosed in the reports we file and submit under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported as and when required and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely discussion regarding required disclosure.
Changes in Internal Control Over Financial Reporting.
There have been no changes in our internal control over financial reporting identified in connection with the evaluation that occurred during our last fiscal quarter that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
| ITEM 1. | LEGAL PROCEEDINGS. |
We are subject to claims and legal actions in the ordinary course of business. We believe that all such claims and actions currently pending against us, if any, are either adequately covered by insurance or would not have a material adverse effect on us if decided in a manner unfavorable to us.
| ITEM 1A. | RISK FACTORS. |
For a summary of risk factors relevant to our operations, see Part 1, Item 1A, “Risk Factors” in our 2021 Annual Report. There are no material changes in the risk factors relevant to our operations since December 31, 2021.
| ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. |
The following table sets forth information with respect to purchases made by us of our common stock during the three months ended March 31, 2022.
| Period | Total Number of Shares Purchased | Average Price Paid per Share ($) | Total Number of Shares Purchased as Part of Publicly Announced Programs | Maximum Number of Shares that May Yet Be Purchased Under the Program (1)(2) | |||||||||||||
| January 1 - 31, 2022 | 46,640 | 8.57 | 46,640 | 630,679 | |||||||||||||
| February 1 - 28, 2022 | 23,878 | 9.13 | 4,194 | 626,485 | |||||||||||||
| March 1 - 31, 2022 | 61,840 | 9.08 | 61,840 | 564,645 | |||||||||||||
| Total | 132,358 | 8.91 | 112,674 | 564,645 | |||||||||||||
| (1) | On April 27, 2021, the Board of Directors authorized an additional stock repurchase plan under which the Company may purchase up to 2,400,000 shares, or 10%, of its outstanding common stock. |
| (2) | Repurchase of 19,684 shares related to tax obligations for shares of restricted stock that vested on February 24, 2022 under our 2019 LTI Recognition & Retention Plan. These repurchases were reported by each reporting person on February 28, 2022. |
There were no sales by us of unregistered securities during the three months ended March 31, 2022.
44
| ITEM 3. | DEFAULTS UPON SENIOR SECURITIES. |
None.
| ITEM 4. | MINE SAFETY DISCLOSURE. |
Not applicable.
| ITEM 5. | OTHER INFORMATION. |
None.
| ITEM 6. | EXHIBITS. |
| * | Filed herewith. |
| ** | Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections. |
45
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 6, 2022.
| Western New England Bancorp, Inc. | ||
| By: | /s/ James C. Hagan | |
| James C. Hagan | ||
| President and Chief Executive Officer | ||
| By: | /s/ Guida R. Sajdak | |
| Guida R. Sajdak | ||
| Executive Vice President and Chief Financial Officer | ||
Western New England Bancorp, Inc. 10-Q
EXHIBIT 31.1
CERTIFICATION
I, James C. Hagan, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Western New England Bancorp, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: May 6, 2022 | /s/ James C. Hagan |
| James C. Hagan | |
| President and Chief Executive Officer | |
| (Principal Executive Officer) |
Western New England Bancorp, Inc. 10-Q
EXHIBIT 31.2
CERTIFICATION
I, Guida R. Sajdak, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Western New England Bancorp, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: May 6, 2022 | /s/ Guida R. Sajdak |
| Guida R. Sajdak | |
| Chief Financial Officer | |
| (Principal Financial Officer) |
Western New England Bancorp, Inc. 10-Q
EXHIBIT 32.1
statement
furnished pursuant to section 906 of the
sarbanes-oxley act of 2002, 18 u.s.c. section 1350
In connection with the Quarterly Report on Form 10-Q of Western New England Bancorp, Inc. (the “Company”) for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James C. Hagan, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| A) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)), and |
| B) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report. |
| May 6, 2022 | /s/ James C. Hagan |
| Dated | James C. Hagan |
| President and Chief Executive Officer |
Western New England Bancorp, Inc. 10-Q
EXHIBIT 32.2
statement
furnished pursuant to section 906 of the
sarbanes-oxley act of 2002, 18 u.s.c. section 1350
In connection with the Quarterly Report on Form 10-Q of Western New England Bancorp, Inc. (the “Company”) for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Guida R. Sajdak, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| A) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)), and |
| B) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report. |
| May 6, 2022 | /s/ Guida R. Sajdak |
| Dated | Guida R. Sajdak |
| Chief Financial Officer |